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ABSTRACT 
The diamino-diamide ligands have been investigated in an 
attempt to develop an antirheumatic drug. 
The ligands N,N'-di-(2-dimethylamino)ethyloxamide and N,N'-
di-(2-diethylamino)ethyloxamide, were synthesised and 
characterised using the physical techniques, NMR, mass- and 
infrared spectrometry. 
The stability constants of the complexes of Mg, Ca, Zn and 
several first transition metal-ions with the ligands were 
determined potentiometrically. 
the curr complexes were 
spectrophotometry. 
The solution conformation of 
determined using visible 
Finally the physico-chemical studies were carried out. 
Firstly by studying the interaction of the copper complex 
with albumin at the physiological pH 7.4 using visible 
spectrophotometry. Secondly by determining the superoxide 
dismutase activity of the ligand by reduction of 
nitrobluetetrazolium using visible spectrophotometry. 
Lastly the ligands and the carr, Cuii, Mgii and Znii metal-






















GLOSSARY OF SYMBOLS 
bovine serum albumin 
overall formation constant, p = metal, q = ligand, 





50% inhibition of nitrobluetetrazolium reduction 
stepwise formation constant 
mass divided by charge 
formation function for the ligand subsystem 
non-steroidal antiinflammatory drug 
negative logarithm of ligand concentration 
prostaglandin E 
2 
negative logarithm of acid dissociation constant 
deprotonation constant 
rheumatoid arthritis 
slow acting anti-rheumatic drug 
superoxide dismutase 
average number of ligands bound per metal ion 
total hydrogen concentration 
total ligand concentration 
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1.1 Rheumatoid arthritis - molecular review 
1.1.1 Inflamed tissue analysis 
Rheumatoid arthritis (RA) is a disease that afflicts mainly 
synovial joints. It manifests itself by chronic 
inflammation, fibrosis and tissue degradation. The nature 
of the disease is so complex that RA is said to be an 





overcorrection due to failure to switch 
correction is done. However, a number 
disorders have 
patients. 
been identified and 
environmental) [3] 
resulting in 
off response when 
of physiological 
implicated in RA 
These are hypohistinaemia 
concentration levels of the 
[ 3-5 ], this implies low 
amino acid, histidine in blood 
plasma, alteration of immunoglobulin (IgG) [1, 6-8] thus 
forming an antibody which is called the Rheumatoid factor, 
RF, and the generation of superoxide by synovial fluids, 
which is higher than normal [8-12]: this is the 
overcorrection process as discussed later. 
Furthermore, in the damaged tissue areas the chondrocytes 
and phagocytes release hydrolytic lysosomal enzymes [13, 14] 
that result in the digestion of the cartilage, especially 
collagen. The pain and joint swelling has been associated 
2 
3 
with prostanoids, particularly the PGE
2 
(prostaglandin E 2 ) 
[15]. 
T lymphocytes which induce class II antigen cells [16], 
interl~ukin I (IL-l) [15] a particular type of monokinase 
has also been implicated. 
The list of metabolites implicated in RA is legion, some of 
these being chain reaction products of the above mentioned 
processes. 
1.1.2 Copper complexes 
Long before the extensive biochemical studies of the 
affected tissues, copper was already associated with RA. It 
is noted that copper homeostasis in biofluids is disturbed 
in RA sufferers, this results in elevated levels of copper 
[6, 17-22]. However, copper is not present in free ionic 
state in RA [3, 23]. 
Copper and its complexes can.have a dual nature. The copper 
amino acid complex of glycine has been found to be an 
irritant [21] - a response which is observed in copper salts 
and metallic copper [9, 24]. Fortunately the beneficial 
effects of copper supercedes the adverse side, more 
especially that copper does not exist in any significant 
amount in free ionic state. 
Low molecular weight complexes of copper have been found to 
collectively have the following healing effects in RA 
treatment. The stabilisation of human gammaglobulin of 
antimicrobial activity and of lysosomal enzymes is observed. 
They are also found to have superoxide dismutase activity by 
controlling the hydroxide and superoxide radical levels in 
blood plasma. The activity of the metalloenzyme, lysyl 
oxidase, which is needed for collagen and elastin synthesis 
is induced by the copper complexes. In the modulation of T 
lymphocyte responses and of prost~glandin synthesis which 
regulate the autoimmune response copper complexes have been 
implicated [129]. 
Copper is among the essential metals of the body. The 
concentration of copper in 
lpg per cm 3 [20, 25,26]. 
ceruloplasmin i.e. 93-95%. 
albumin, 4%, which is 
human plasma is reported to be 
Most is firmly bound to 
The remainder 





exchangeable low molecular weight fraction bound to amino 
acids [21]. This fraction is considered to be the immediate 
transport form of copper [25, 27-31]. 
The liver, brain, heart and kidney are the organs which 
contain the highest concentration of copper with the liver 
accounting for 10% of the total [20, 32, 33]. The liver is 




As much as the disease is complex, the approach to the 
treatment has also proved to be just as complex. In the 
trial and error process to get to the relevant drug, two 
classes of drugs have been identified. The non-steroidal 
antiinflammatory drugs (sometimes called the non-specific 
antiinflammatory drugs) and the slow acting anti-rheumatoid 
drugs (sometimes called the specific anti-rheumatoid 
agents). The mode of action on RA differentiates between 
these drugs - either by suppressing certai.n compounds of the 
inflammatory response or in reducing symptoms and signs 
associated with inflammation. 
The NSAIDs have not been shown to alter the course of the 
disease [34], although they do induce antiinflammatory 
activity. Generally they have been found to have the 
capacity to inhibit cyclooxygenase activity [35]. This 
results in lowering of PGE
2 
concentration in synovial fluid 
[36, 38]. Therefore the NSAIDs have analgesic activity or 
are pain killers since PGE is known to be associated with 
2 
pain (see Section 1.1.1). 
Notwithstanding their activity, the NSAIDs have several side 
effects. These include gastrointestinal toxicity [39], and 
development of renal toxicity in patients since PGE has an 
2 
important renal function [40]. Also in patients using 
anticoagulants, gastrointestinal bleeding may be caused 
[41]. 
Of the SAARDs, the most used and well studied is D-
penicillamine [42, 43]. It has been found to be very 
effective in altering the course of the disease. ~his could 
be due to its resemblance to one of the amino acids, 
cysteine, [34]. Its mode of acti.on is thought to be via its 
ability to bind firmly to plasma proteins, including 
albumin, a-globulins and ceruloplasmin via the disulfide 
linkages [44]. 
Like all other drugs that are being currently used it has 
its side effects. Collectively these are optic nuritis, 
proteinuria, marrow aplasia, rashes, nausea, loss of taste 
acuity [5, 45, 46] and increase in histidine levels [5]. 
A combination of drugs is sometimes used and seems 
effective, particularly 
One example of 
hydroxychloroquine (an 
increases the levels of 
stabilises the level. 
in the reduction of side effects. 
this is D-penicillamine and 
antimalarial) [46]. D-penicillamine 
histidine while hydroxychloroquine 
The noticeable fact about the above drugs is that, given on 
their own, they can be toxic over long-term administration. 
However, copper complexes of both the NSAIDs and the SAARDs 
6 
7 
are less toxic or have improved activity than the parent 
drug on its own [6, 47-52]. 
There are very few low molecular weight complexes that have 
been found to be irritants resembling the copper ions [24, 
47]. 
None of the above drugs were designed specifically for RA 
[3, 15, 34, 53-55]. They were discovered either 
accidentally or by trial and error. That a drug specific 
for RA has not been designed to date is understandable when 
considering the complexity of the disease (see Section 
1 • 1 • 1 ) • 
8 
1.3 Drug design 
1.3.1 Requirements 
. 
Drug designing per se is a complicated issue. There are 
quite a number of approaches to the method. No single route 
can be considered as the best. For instance, biological 
fluids, being an equilibrium system, the presence of added 
exogenous ligand or metal ion will result in a new 
equilibrium distribution [56]. The prerequisite for 
rational drug designing is the knowledge of the various 
metabolic reactions in the biofluids [55, 57]. Derived from 
this will be the ability to distinguish between a 
physiologically healthy and disease condition at the 
molecular level [58]. From the molecular structure, the 
design will be restricted to functional structure [57]. 
In RA the metabolites have been studied bearing copper ion 
involvement in mind (see Section 1.1). The metal binding 
sites on the protein have been identified and well studied 
[3, 15, 28, 29, 59-61]. Another approach has been the 
investigation of the mode of action @f ·.the present drugs. 
This was to help the researchers understand the disease 
better [6, 15, 34, 45]. 
Armed with the above information, drug design could seem to 
be long overdue. There are, however, a number of 
limitations which need to be considered when designing a 
drug. First and foremost, drug availability on the inflamed 
site has to be considered. Pharmacologically a drug is 
considered to be distributed in two different fractions in 
blood plasma [62]: 
(a) bound to proteins 
(b) free form likely to penetrate the tissues 
Varied serum binding of the drug to the biofluid species can 
affect pharmacokinetics and pharmacodynamics of the drug. 
This can in turn cause different tissue levels of the drug, 
hence toxicity [60]. The mode of uptake of the drug will 
also be restricted by cells other than those the drug's 
action is intended for [59]. 
The free form of the drug will have its activity governed by 
its electrical neutrality. For diffusion into tissues, the 
drug has to be electrically neutral [56, 62, 63]. Stability 
and solubility of the drug in tha different media of the 
body, at different pHs, is also essential. In acidic 
medium, the stomach, some insoluble compounds can be 
dissolved [47] possibly resulting in alteration of the basic 
structure or active core. Therefore gastrointestinal 
absorption is considered first in bioavailability of a drug 
[64]. Metalloactive drugs have to be specific for that 
particular ion. It has been found that drugs may interact 
9 
10 
with trace elements [62, 65] thus disturbing the metal ion 
homeostasis in biofluids. 
1.3.2 Drug modification 
Drug modification has been proved beneficiary in agents that 






as drug carriers have been synthesised 
[59]. The· synthesised oligopeptide 
be resistant to degradation on 
the cell. This will enable the polymer 
drug complex to remain intact and stable during its journey 
in the plasma. 
the drug core is 
disease. 
This approach is with the assumption that 
the active form required to treat the 
Sometimes it can be difficult to design a metabolism-safe 
drug ~hat is likely to keep its pharmacological activity. 
Two methods of modifying the drug have been investigated -
the analogue and the prodrug approach [57]. The analogue 
approach has been found to suffer from major structure 
change in the drug, that often has negative effects on the 
pharmacological behaviour of the compound. Bioreversible 
derivatives of known pharmacologically active compounds are 
1 1 
produced in the prodrug approach. The latter approach gives 
rise to three possibilities: 
1 ) prodrugs aiming 
bioavailability 
at enhanced absorption and 
2) prodrugs aiming at prolonged duration of effect of ~he 
parent compound 
3) site specific prodrugs which will preferentially 
convert to active drug via the action of unique enzymes 
present in the target organ or tissue 
Metal chelates of the parent compound can be made which are 
not susceptible to enzyme degradation [66]. By this, 
bioavailability of the active ingredient is increased as 
compared to that of the compound alone. 
The multiple interrelated cellular and molecular process of 
RA is borne in mind. It would seem that any drug which 
interrupts a sequence in the self-perpetuating inflammatory 
process may be beneficial. 
12 
1.4 Proposed research 
Based on the above evidence, it is therefore sensible to 
design a drug that is copper chelating. Jackson et al.[58] 
have schematically summarised the approach that the copper 
chela tor can take. The present research ~b~¥ts-tfiis ~in,·::~~;:;~~::f). 
~ ·--, -~ ~ -· ~·--~·..,::~' 
mind in the design of a drug. 
It is well and good to design the· structure of the active 
compound, but it will have to be tested for its 
pharmacological activities with respect to biofluids. The 
low molecular weight fraction of metal ion complexes cannot 
be monitored in vivo by instrumental techniques. This is 
due to the concentrations which are several orders of 
magnitude below those identifiable by research equipment. 
For this reason a computer model of blood plasma has been 
developed [26]. This model has been used widely and 
upgrading occurs at regular intervals in accordance wit.h 
more information about biofluids being obtained. A series 
of computer programmes can be used to study and give 
structure of target protein, also to determine stability 
constants of the designed ligand-metal complex and model the 
ligand-metal complex behaviour in blood plasma. 
The results from the latter can be integrated to predict the 
efficacy of metal binding in plasma. This takes into 
account changes in the ligand concentration with time. If 
13 
the drug's pharmacological tests are promising, the results 
from integration can help in deciding the delay in 
treatments for animal screening. 
In this reseatch the study of structure of the target 
proteins will not be undertaken. Literature search provided 
for this first step (Section 1.1). It is partly from the 












where n is Q. 
The aim of the research is to: 






' N~N·~di-(2-dimethylamino) ethyloxamide {DMO) and 
'" N~N-~di-(2-diethylamino) ethyloxamide (DEO) fall into the 
diamino-diamide ligands category. 
There is a wide variety of these ligands which have been 
studied from linear to macrocyclic structures [68-78]. 
These ligands have been found to resemble peptide chains 
which are associated with copper binding in the body. 
In all the studies carried out, it has been found that the 
amide protons are displaced by the metal ion, this is a 
unique situation. These protons are not easily removed 
since the charge is depicted as: 
0 
I (-) 
--C , , 
~' 
N 
thus making it difficult to remove the proton that balances 
the charge. 
Previous studies with regard to RA have shown that a ligand 
which is more likely to mobilise copper [84] and also show 






Structures which are based on this core have been studied 
[84, 85]. 















(DPA) and II ethylene-diamine 
diacetic acid (EDDA). They have been found to form neutral 
complexes and also mobilise protein-bound copper. However, 
DPA does not possess sufficient structural advantage over 
naturally occurring ligands to make it a better copper 
chelator. EDDA is non-specific, zinc and calcium have been 
found to compete with copper and effective copper 
complexation is lost in blood plasma. [84] 
Other variations of the core structure above have been 
studied generally [77]. These also do not exhibit any 
specificity. 
coo-
The diamino-diamides were studied 
ability to bind divalent metal ions 
transition elements. 
18 
with respect to their 
especially the first 
Trien which has been widely studied as well as in Wilson's 
disease [79, 80] for its copper binding served as the core 
structure of the present research. This choice is based on 
the findings that the amino groups are the stabilising 
factor in the metal complexes formed with diamino-diamides 
[70]. It was apparent therefore that in order for the 
ligand to be selective towards copper, the amide should have 
all four nitrogens available for binding. 
The choice of the site of the amide carbonyl group (-c=O) 
came about by studying work done previou~ly [68, 76, 81]. 
Liu and Chung in their study showed that addition of a polar 
group -OH in their case improved reactivity. The addition 
of an alkyl group reduced reactivity. Kodoma and Kimura 
have studied other similar ligands with respect to cation 
selectivity of macrocyclic tetramines as found in 
macrocyclic hexaethers. They found that stability of the 
copper complexes increased with amide macrocycle and reached 
maximum stability with :a 5,6,5,6 ring cluster. 
A characteristic of the diamino-diamides is that they form a 
cluster of rings with the metal ion in the centre. The 
19 
effect of the ring size has also been studied [79-83]. The 





is the most reactive and most stable. Moreover with regard 
to copper complexes the macrocycle: 
N N ----, 
"'"M / 
/"" N N--------
has been found to have a higher formation constant for the 
neutral species CuH L [68]. 
-2 
However, copper has a small 
20 





would be an appropriate choice. This structure looks 
somehow strained but it has been suggested that the cis 
conformation is most stable [82] with no distortion in the 
bond angles. A similar structure 
nickel [76]. 
Armed with the above information the ligands chosen were: 
0 0 






with R an alkyl group CH or CH -CH • 
~ 2 3 
The alkyl groups 
replacing the hydrogens in the previously mentioned ligands 
should provide rigidity to the structure thus mimicking the 
macrocycles. 
The alkyl groups were also a result of a comparison with the 
macrocycle [68] which showed improvement on the 
complexation. 
Rigidity of the structure would also limit the ring opening 
effect thus allowing only smaller ions inside the cage. The 
alkyl groups have to be small to avoid bulkiness and hence -
crowding which would limit the transfer of copper ion to the 
relevant tissue in vivo. 
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2.2 Synthesis of DEO and DMO 
2.2.1 Preparation of compounds 
The reagents used were all from Aldrich chemicals and were 
used without further purification. The solvents used wer~ 
tetrahydrofuran (THF) dried over sodium wire and absolute 
ethanol (EtOH) dried over molecular sieve. 
Method 
The reaction was carried out under dry nitrogen and in an 
ice bath to slow down the reaction. 
Into a dry two necked round bottom flask the required mole 
equivalent of the amine was poured. About 20cm 3 THF was 
added. The required mole equivalent of the ox_<i!iYl~,~chlorfde Xn_,·.· 
THF was added slowly while stirring. A white precipitate 
formed immediately. The reaction was allowed to complete. 
The mixture was filtered and the precipitate washed with 
THF. 
recrystallised from hot ethanol and then stored in a 
desiccator over silica gel. The product was the 
hydrochloride form of the ligands. The percentage yield was 80% 
for DEO and 82% for DMO. 
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2.2.2 Analysis of ligands 
For microanalysis, the Heraueus CHN-rapid analyser was used 
while the Reichert Thermovar was used to determine the 
melting point. 
TABLE 1 
microanalysis calculated found 
% C H N C H N 
39.61 7.97 18.48 39.2 7.4 18.35 
46.79 8.97 15.59 46.8 8.9 15.60 




2.3.1 Nuclear magnetic resonance (NMR) 
The Varian VXR 200 Spectrometer was used to obtain the 
spectra of DMO and DEO, shown in Figures 1 and 2 
respectively. Table 2 represents the identified peaks. 
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TABLE 2 
ligand nucleus o (ppm) rel type no of 
integration (ern) peak assignt protons 
_.. CH1 
Dr.D lH 2.95 6 s "''c.H 1 12 
/ (\1~ 
3.4 2 t 1\'I.C.- N,(\4 4 ~ 
3.72 2 t 
~ c- t-1- c~o~'l. 4 
l3c 34.69 s N / C.\4 3 ..... ( 14'1. 
43.11 s C. H~- N ( 
56.11 s -1-11'1- (loll. 
161.09 s o= c.- N 
DEO lH 1.2 t 
r- <H 
N } 12 
'---Ck 
l 
3.18 q N- til,_- 8 ..... c~-~,__ 
3.26 t (H'l.- N':_ 4 
3.6 t O<:.N- C. H"l. 4 





48.62 C.!-1 _N,--. 
l. "-· 
50.85 'N - cy ~ 
161.91 O=c.-N 
s = singlet, t = triplet, Q = quartet 
lH NMR relative to DSS 
l3c NMR dioxane as internal standard 
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2 o 3 o 2 Mass spectrometry: 
The VG Micromass 16F mass spectrometer in tandem with Carlo 
Brba gas chromatograph was used to analyse DMO and DEOo 
The fragmentation pattern for DMO can be represented in the 
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Mass spectra of (a) DMO and (b) DEO 
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These ligands behave in a peculiar manner. As can be seen 
from the mass spectra and in the proposed fragmentation 
pattern in Scheme 1, they behave as amines. Peaks of 
highest intensity are those of pathway (a) in both cases. 
The confirmation of the hydrochloride is observed in peak 
m/e 36 for HCl which is in the expected isotope ratio. 
2.3.3 Infrared spectroscopy 
The Perkin Elmer 983 Infrared spectrophotometer was used for 
the characterisation of DMO and DEO. 
analysed as Nujol mulls. 
The samples were 
The infrared spectra of DMO and DEO are shown in figures 
4(a) and (b) respectively. 
As these ligands have both characteristics of amides and 
amines they should .1 _;present some interesting study. 
Properties that are known to be characteristic of ami des are 
I 
the following, they have amide I band due to C=O and amide 
II band due to NH. The amide I band has its position being 
determined by the degree of H-bonding and the physical state 
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: Infrared spectra of (a) D~10 and (b) DEO 
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spectra since amide groups can bond 
[88] the 
R 
~ --;;::/ 0 • • • • H~ 
and 




R 1~ ~H 
Rl 
~ 






















the C=O absorption of amides occurs at longer 
wavelengths than "normal" carbonyl absorption due to 









In characterising the spectra only bands due to either the 
amide or amine groups will be reported as .the fingerprint of 
the ligands. 





















NH and CH stretch in amide 
tertiary amine salt absorption 
band 
amide I band due to C=O 
NH amide II band 
CN stretch of amide 
CN stretch of amines 






In principle, as the basis for determining stability 
constants, any property which varies with the degree of 
complex formation can be used. However, quantitative 
relationship between the property and nature of the species 
present is essential. Broadly the experimental methods for 
determining stability constants fall into two categories. 
These are the spectroscopic and electrochemical methods 
where the observable property is proportional to the number 
of molecules and activity respectively. 
Potentiometry has been, and still is, the most popular 
method for the determination of formation constants. This 
is due to its high accuracy and precision [90]. With the 
advent of sophisticated computer programs [91-93] the 
precision of data interpretation has been improved 
considerably. 
The glass electrode has a wide applicability and is 
dependent on the hydrogen ion activity. However, below pH 2 
and above pH 12 this is no longer applicable. In these 
regions ion concentration is predominant and recalibration 
of the electrode is necessary to maintain linearity of the 
Nernst equation. 
E = Eo RT + zF ln 
36 
3.2 Theory 
Consider a metal M, and ligand L, in solution. The activity 
of the complex formed is related to the activities of the 
reactants M and L thus: 
( i ) 
where K' is the .t1ie-rmp4}:}1mrti~~::$tabi!:it;)~- constant 
- --.~ .. _ J 
However, in practice mai... analytical techniques yield 
concentrations rather than activities. In turn, activities 
are related to concentration by: 






where Y is the activity coefficient of the species. 
( i i) 
The experimental determination of activity coefficients is 
very difficult. This problem is overcome by working at 
constant ionic strength. Under these conditions YML/YM YL 
is a constant and the equation reduces to K = [M]/[M][L] 
where K is the s:toi~h~~)~~tEic::_ ·> s tabi 1 i ty constant. 
The stepwise formation of a complex can be described by a 
set of stability constants: 
M + L ML 
ML + L ~ MLn n-1 ' 
(ML) 
K1 = (M][L] 
where Kl····Kn are stepwise stability constants. 
37 
( i i i ) 
(iv) 
The above stability constants can be represented by the 
overall stability constants, f , where: 
Sn = K1K2•••Kn 








The possibility of formation of protonated, hydroxo or 
oligonuclear complexes can be taken into account by 
subscripts, for example M L H , hence: P q r 
rM L H 1 l" p q r •.• (viii) 
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There are a number of secondary functions that are used in 
the determination of stability constants. The ones used in 
-this study are the Z functions [93], which can take the 
form: 
for ligand protonation studies and: 
= TL - A 0 + L:nSLHn 
TM 
( ix) 
( X ) 
-
for metal complexation studies. A plot of ZH against pH and 
ZM against pA is used to evaluate the experimental and 
calculated functions E obs d K an 
calc . 
EK respect1vely. from 
Another function is Q, the deprotonation function. It is 
only defined for the binary (MLH) and ternary (MLXH) 
systems: 
(Xi) 
where TH* is calculated total concentration. of protons in 
the system at the experimental pH ignoring the presence of 
-all metal complexes. In the plot of Q against pH the 
formation function for the ligand subsystem n, is plotted as 
a solid line (see Figure 1). 
n = 




Q is the average number of protons, per metal-ion, displaced by complexation, 
while n is the average number of protons bound to the ligand in the absence 
of any metal-ion. For example, if Z ~ 1, Q ~ 2 and n = 1. This implies 
the presence of the species MLH_1. On the other hand, if~= 2 with still 
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FIGURE 1 The (a) formation and (b) deprotonation curves 
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3.3 Computing 
ESTA [ 93] a computer program library which performs 
calculations concerned with competitive aqueous solution 
equilibria, was used in the analysis of the potentiometric 
data. 
The overall analysis is performed via two major modules, the 
simulation (ESTA 1) and the optimisation (ESTA 2) module. 
Simulation of theoretical data and curves can be carried out 
using the ESTA 1 module. The two functions that play a 
major role are the Q and Z functions. The Q is a unique 
function that helps or supports the interpretations of the Z 
function curves. To show this consider the formation curves 
of a particular system (Figure l(a)). Looking at the curves 
the interpretation can be that these curves show a stepwise 
formation of either protonation of a complex or the 
formation of ML species. 
2 
The fanning out at the high pH 
. .·-".. . - -· ~' 
region could( indicate the pres·ence· of a ~y..d,'ftl~t spec.:ie? :::~,i..: .~ ·. ~· 
or deprofona.te~-~-> species in the ·solution. The z function on 
its own is not easy to interpret and typically so in this 
case. The Q function (Figure l(b)) shows the following: at 
the beginning of the titration ~ is level at ~ = 2 and the Q 
function at Q = 1.0. In this region the predominant species 
is the MLH species, because the ligand has two protons and 
it has lost one due to complexation. Beyond pH 5 the two 
curves are superimposable indicating the presence of a ML 
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species. As stated, the interpretation of the system is 
easier when using both the Z and Q functions. 
The Q function is also useful combined with the optimisation 
module ESTA 2. Modelling of the system can be carried out 
with confidence. An example of this combination is observed 
~n~ Figures 2 and 3. Figure 2 shows a large discrepancy 
between the observed and the calculated Q function values. 
If the other titrations in the system agree with the 
proposed model, then usually refining the E 0 and acid in the 
vessel of this particular titration in Figure 2 would result 
in a more acceptable model. This is shown in Figure 3, 
which is result of the optimisation of the E 0 • 
The optimisation module has an interesting feature in that 
it can be used to simultaneously optimise the formation 
constants and other titration parameters such as 
concentrations, initial volumes, electrode slope and 
intercept. Optimisation of formation constants together 
with other parameters has been shown to significantly reduce 
the effect of systematic errors in the data (Figure 4). [97] 
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The optimisation is performed by minimising an objective 
function, U. 
1 N 




-1 w . (Yo . - Y ·c) 2 n1 n1 n1 
using the Gauss-Newton method. 
The weight at each titration point is calculated using 
w . n1 
the Hamilton R-factor is given by: 
R = 
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A schematic flo~ diagram of the route tollowed when using 
the ESTA library for analysing data in this research is 
shown in Scheme 1. The dotted line box in the scheme 
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Schematic flow diagram of the ESTA library used 




All solutions were prepared using glass distilled deionised 
and degassed water. All titrations were done under high 
quality grade nitrogen (Air Products) and passed through: 
1 ) 
2) 
15%. 1,2,3 trihydroxy benzene in 
50% KOH to remove ·CO '' _ _2 




NaCl to humidify the gas 
To control the ionic strength, all solutions were maintained 
-3 
at a chloride concentration of 150mmol.dm by the addition 
of sodium chloride (SAARCHEM ANALAR). 
All the metal i.on solutions were prepared from their 
chloride salts (SAARCHEM ANALAR) and standardised by 
complexometric titration using EDTA [95] and by Gran plot 
[96] for hydrogen ion concentration. Sodium hydroxide 
-3 
solution (lOOmmol.dm ) was prepared- freshly and weekly from 
Merck concentrated ampoules, under nitrogen and standardised 
using potassium hydrogen phthalate [95]. Hydrochloric acid 
for calibrating the electrode 
-3 
(lOmmol.dm ) and also that 
for titration 
-3 
(lOOmmol.dm ) was prepared from BDH standard 
concentrated acid and standardised by Gran plot. Stock 
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solutions of the ligands were prepared and standardised 
potentiometrically. 
All solutions that were in use in one particular time were 
kept under nitrogen in polyethylene bottles. Storage of 
other solutions was also in polyethylene vessels with 
exchangeable tops with the titration vessels. 
The titrations were performed in a double w~lled vessel 
(Metrohm) thermostatted at 25 + 0.1 °C by circulating water 
(Heto thermostat). The emf reading:~\ W'_{'!g~ measured with a 
Radiometer PHM 84 research pH meter equipped with a Metrohm 
glass electrode and an Ag/AgCl reference electrode (Metrohm) 
-3 
with a renewable liquid junction of 150mmol.dm chloride 
concentration. The titrating solution and all other 
reagents except ligands were added from a piston-burette. 
The titrations were automated (UCT electronics) and data 
stored on floppy disc. 
Due to the complexity of the potentiometry, which was 
plagued by precipitation, the date were analysed using the 
scheme outlined below. The precipitate was analysed and 
found to be the hydrolysed metal. 
A number of approaches have been tried in attempting to 
analyse the metal-ligand titration data: 
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a) Editing where the precipitate started and concentrate 
only on a shorter section of the titration 
b) Performing the titration in both directions i.e. from 
high to low pH and from low to high pH 
c) Splitting the data into two sections, one at high pH 
and the other at low pH which could then be analysed 
separately 
The first approach (a) was limited in that only the 
protonated species could be analysed for, although it gave 
good statistics on refinement. The region was also far from 
the physiological pH of 7.4, which is of interest in this 
study. The second approach (b) had its shortcoming in that 
because of the limitations of the available computer 
programs the number of dissociable protons of the ligand had 
to be changed. High arbitrary values for the protonation 





species. Finally the approach (c) had the disadvantages 
that when combining the separate refined sections 
convergence could not be obtained. 
The final solution was to repeat the titrations at very low 
concentrations of both the metal and the ligand and 
.. ·:to· analyse: the_ dat-a over' the=:e:ntire pH range~~-~-
- .· .... ·- ,-
-...: , --
.... ~:: -~·.~:,:J~ ~- - .... ~ 
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the consequence of high standard deviations on the s values 
of the order of 0.05. This had been found to reflect the 
"true" species present in the solution although being 
hampered by the presence of small amounts of 
. -")-·· .'· 
(_!~. :·. 
precipitate. Sometimes the precipitate could not be seen, 
but on data analysis it could be detected. 
In most of the data analysis the approach sug~ested by May 
and Murray and outlined in the theory section has been 
adopted. This entailed simultaneous optimisation of 
the values, the E 0 and the concentration of the acid in 
the vessel. 
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3.5 Analysis of Data 
3.5.1 Protonation studies (H -DMO and H -DEO systems) 
Figures 6(a) and 6(b) show the protonation curves of DMO and 
DEO respectively. The symbols represent different ligand 
concentrations while the solid lines represent the 
theoretical curves calculated using the constants given in 
Table 1. Although there are two amine nitrogens, the 
titration curves show only one inflection. This is because 
the pKa values of the two amines are so close they are 
titrated virtually simultaneously. Table 1 shows the final 
protonation constants together with the relevant statistics. 
From these statistics and Figure 6(a) and (b) it can be seen 
that the agreement between theory and experiment is good. 
Both these ligands are more acidic than the trien on whose 
structure they 
9. 31 [l[fJ_.\ 
interpreted 
are based. Tr i en ha.s pKa values of 10 ·.-0 9 and 
The difference in the pKa values can be 
by considering the following concepts. 
Generally it is known that the base strength in nitrogen 
donor ligands depends on the availability of the nitrogen 
lone pairs of electrons. Consider NH , in water i'~ is a weak 
- 3 •) 
base. In this state the nitrogen atom is experiencing the 
inductive effects of the hydrogen atoms and is therefore 
partially negatively charged. On replacing the hydrogen 
with an electron withdrawing group results in decreased 
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which has pKa values of 9.31 and 8.43 with trien whose pKa 
values are 10.09 and 9.31. This decrease in the pKa can be 
attributed to the introduction of the amide groups to the 
trien structure. 
Alkyl groups are more electrondonating than hydrogen atoms 
therefore replacing the hydrogen atoms with an alkyl group 
will result in increased basicity which is caused by an 
increase in electron density on the nitrogen atom. 
Increasing the number of alkyl substituents on the nitrogen 
also results in increase in the basicity, however, not as 
much effect as the initial substitution. The tertiary 
substituted alkylamines are less basic than their primary 
substituted counterparts. This anomaly has been explained 
by the solvation effect [99]. Hydrogen-bonding solvation 
tends to increase the apparent strength of amines. In the 
positively charged ammonium ions solvation occurs more than 
in the uncharged amine, resulting in enhanced ba.sici ty of 
the amine. 
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+ 4H 0 ~ OH + .·. R - N + H . . . 0 
2 H '-..H • . 
0 
/ " H H 
Therefore based on the above argumentspit follows .that the 
decrease in basicity of trien on going to DMO and DEO is due 
to both factors discussed above. - The electronwithdrawing 
amide group on the central ethylene group and also the less 
solvated tertiary amine groups. The difference in the pKa 
values of DMO and DEO can be attributed to the inductive 
effect of the alkyl groups increasing the electron cloud 
around the amine nitrogen e.g. 
Me 3N = 9.72* 
Et3N = 10.72 
which is electrondonating substitution. Therefore DMO and 
DEO do succumb to the rules of the nitrogen donor ligands. 
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Logarithms of the overall formation constants, B pqr for the 
H -DMO and -DEO systems, determined in this study at 25°C 
and 0.15 mol.dm 
-J 
Na[Cl] 
Pkw used = 13.59 
ligand B-pqr ..J23E u R pH range 
< 
DMO 011 6.848 + 0.0001 16.2 0.01 3 ... 9 -
012 12.80 + 0.001 -
DEO 011 7.04 + 0.002 18 0.01 -
012 13.256 + 0.001 -
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3.5.2 Copper 
Figures 7 and 8 show the formation curves for the Cu-OMO and 
-DEO systems respectively. The symbols represent different 
metal to ligand concentrations. The curves are superimpos-
able showing no existence of polynuclear species. At the 
beginning of the titrations the protonated species hump is 
observed, but the theoretical curves 7(b) and 8(b), plotted 
using the formation constants in Table 2 do not show any 
agreement in this region. This region, however, is also a 
high error region as shown by the big jump in the emf value 
from the first titration point to the second. However, on 
removing the MLH species frbm the refining process the 
statistics are very high and convergence is not achieved. 
In the species distribution curves, Figures 11 and 12, it 
can be observed that at the start of the titration about 20% 
and 40% of Cu in Cu-DEO and Cu-DMO systems respectively has 
been complexed. Continuing with the titration it can be seen 
that the curves show a typical step-wise formation sequence 
up to Z va.lue of one. In the low pA region 
deprotonation is seen to take place. This is shown by the 
"backward fanning" of the titration curves. 
Table 2 shows the formation constants of the Cu-OMO and 
Cu-OEO systems. There is · ~- :;. agreement in the observed and 
theoretical results as seen from Figures 7(b) and 8(b). The 
objective functions, u, are much lower than 100, which shows 
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that the true values are approached [100]. The two systems 
are similar. 
The Cu-DEO system has formation constants lower than those 
of the Cu-DMO system with the average difference of about 
0.2 log units. This is in accordance with the pKa values of 
DEO being higher than those of DMO. Therefore, the lowered 
metal complex stability could be attributed to the inductive 
effect of the groups on the amine nitrogen. 
For the DMO equilibrium 
MLH ML + H 
it can be seen that the pKa is 3.'0, which is lower than pKa 1 
6.85. A similar effect is shown by.DEO, 3.4 and 7.04 for 
deprotonation of the complex and ligand respectively. This 
decrease in pKa upon coordination of the metal ion cannot be 
due to an inductive effect of the Cu 2 +~ as coordination is 
occurring at one end of the molecule and deprotonation is 





On the other hand, if the postulated structure is accepted, 
then it can be seen that it is not the protonated amine that 
becomes deprotonated but the amide nitrogen. This would 
account for the pKa values obtained. 
The relationship between the Cu-DMO and -DEO can be further 
interpreted by considering the substituted amine's 
complexation constants, Table 3 [101]. 
The monodentate ligands show a decrease in the ML formation 
constant with increase in the number of alkyl substituents 
on the nitrogen. The same trend is observed with BAO and 
DMO. A similar trend is envisaged for the DEO system. The 
difference in the stability of the ML species between the 
two sets of ligands is in their structure.· Trimethylamine 
is a monodentate ligand while BAO, DMO and DEO are 
potentially multidentate. 




CH -- N----+ Cu 2 + 
3 
Two possible structures for the 
0 0 
" ij c-- c 








species more steric hinderance is 
expected with the diethyl than the dimethyl substituent 
leading to a lower stability. However, the difference in 
the formation constants of the MLH of the DMO and that of 
-2 
the DEO is minimal. A solution to this problem and that of 
the DEO is ethylene groups which could possibly create a 
hydrophobic end of the structure. 
CH-CH 
2 3 
Figures 9 and 10 show the deprotonation function Q of the 
Cu-DMO and Cu-DEO systems respectively. The overall number 
of protons that the ligand is capable of losing during 
complexation is four, but only two protons are titrated 
during protonation, the other two being amide protons. With 
reference to the Cu-DEO system, it can be seen that at pH 
3. 0, Q = ·'Q;? ·.: which means that one proton has already been 
lost although n is still at 2. This is acceptable in the 
light of the previous explanation. At this stage "three" 
protons are still on the ligand. At pH 5, Q = 2 and n = 2 












Cu-OMO formation curves 
2 
(a) 0 0 2.5:5.6 mM 
0 ~ 2.6:5 mM 
0 0 3:4.7 mM 
0 0 3.8:4 mM 
0 ¢ 
0 ~ 
0 ~ A 
0 ~ A 
0~ A 
0 ~ A 
0 ~A 













0 ~ A 
0 ~ 1:::.. 
0 ~ ~ 1:::.. 0 
0 t' cf 
~A 




4 5 6 7 
pA 
8 9 
FIGURE 7 Experimental (a) and theoretical (b) curves for 
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FIGURE 8 Experimental {a) and theoretical {b) curves for 
the Cu-DEO system at 25°C and 0.15M {Na) Cl 
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TABLE 2 
Logarithms of the overall formation constants, s pqr for the 
Cu-DMO and -DEO systems, determined in this study at 25°C 
and 0.15 mol.dm 
_3 
Na[Cl] 
Pkw used = 13.59 
ligand pqr ~ u R pH range 
DMO 111 12.24 + 0.04 51 0.06 3 - 8 
110 9.2 + 0.03 
11-1 3.44 + 0.04 -
11-2 -2.94 + 0.03 -
DEO 111 12.16 + 0.04 76 0.05 3 - 8 -
110 8.74 + 0.02 -
11-1 3.74 + 0.02 -
11-2 -2.98 + 0.01 -
65 
TABLE 3 








































' ' . 
'· 





- - ({Zl~<t~oQDA 
···---- .... ----- --· -- (i)"CJL!-o--~~- ~ 
al 
0 
.e ·- .. , 
1 
' ' 






3 4 5 
pH 
6 7 
~he (a) experimental and (b) theoretical curves of 
Q vs BH for the Cu-DHO system at 25°C and 0.15M 
(Na) Cl ... ~ n vs pH 
67 










' ' ' ' 
1 ~ 
-, 
Cb ' " ' ., 











' '· ., 
' 




3 4 5 
pH 
6 7 
~he (a) experimental and (b) theoretical curves of 
Q vs pH for the Cu-DEO system at 25°C and 0.15M 

























































The species distribution curves for the Cu-DMO system showing the percentage of 





























































The species distribution curves for the Cu-DEO system showing the percentage of 
copper in each species in 1.5 : 1 ligand-to-metal solution at a concentration of 4mM. 
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formation. Above pH 5 the complex continues to lose protons 
-
(Q increases), with Q = 3 and n = 1. This is the 




,~-=~-~--..:_-· -- At pH 8. 25 complexation is complete with Q = 2 and 
n = 0 which means that a total of four protons have been 
lost and the MLH_ 2 species has been formed. 
Figures 11 and 12 show the species distribution at different 
pH values. These represent the percentage of the Cu 2 + ion 
present in each species. In agreement with the Q it can be 
seen that at-"the beginning of the titration 20% of the 
copper has been complexed in the form of MLH. 
3.5.3 Zinc 
Figures 13 and 14 show the formation curves for the Zn-DMO 
and -DEO systems respectively. The symbols represent 
different metal to ligand concentrations. An interesting 
feature arises from the ill-defined shape of the Zn-DEO 
formation curves. During the titrations gross precipitation_ 
occurred in both systems, but was excessive in the Zn-DEO 
system. In explaining the processes taking place in the 
solution, the following discussion has got to be introduced. 
Firstly, it is known that the Znii ion does hydrolyse in 




3 + and precipitation commences in the neutral region 
[102]. Secondly, solutions containing such small amounts of 
71 
hydrolysis species are poorly buffered. The Zn precipitate 
obtained in this study was taken for microanalysis which 
proved it to be the hydrolysed metal ion and not the Zn-DEO 
complex. Despite the difficulties encountered in the study, 
careful use of the data analysis scheme helped in obtaining 
the constants in Table 4 which were subsequently used to 
plot the theoretical curves in Figures 13(b)and 14(b). 
There is agreement in the shape of the curves of the 
theoretical and the observed systems. 
The data analysis does not show any stepwise formation from 
MLH---)> ML + + H • There is a huge jump in the deprotonation 
process in that the protonated complex loses two protons of 
the total of ~four~ that the ligand is capable of losing, 
forming MLH , which is the result of the loss of three 
-1 
protons. The ML species was included in the modelling of 
the species in the solution, however, on refining the 
formation constants it gave such high error that it was 
excluded. It was further assumed that if ML is there it is 
in very little amounts that are not significant or that it 
is an intermediate in the fast reaction 
MLH ~ [ML + H] ~ MLH _
1 
+ 2H+ 
In the low pA region there is backward fanning which is 
indicative of the presence of hydroxy species i.e. 
deprotonation of the complex takes place. 
72 
Table 4 shows the formation constants of the Zn-DMO and 
Zn-DEO systems. There is good agreement in the observed and 
theoretical results despite the presence of precipitate. 
~ 
The objective function U is much lower than 100 showing that 
the true value under these conditions was approached. 
As with the previous complexation studies of DMO and DEO 
with H+ and Cu 2 +~ the inductive effect of the ethyl group 
over the DMO is obvious. The formation constant of the 
fully deprotonated complex for the Zn-DEO system is lower 
than that of the Zn-DMO system. However, the opposite is 
observed with the MLH and MLH_
1 
species. This could mean 
that because the DEO is more basic than DMO it is more 
inclined to form stable complexes with Zn. This cannot be 
explained in terms of the inductive effect. An explanation 
could be that the ethyl groups form a stable rigid 
hydrophobic end by packing on top o£ each other therefore 
limiting the amount of "sweep" of the alkyl groups around 
the nitrogen atom. Steric hinderance in the case of DMO 
could therefore result f~om the relatively free methyl 
groups that revolve around the nitrogen atom. In this way 
the methyl groups could be forcing the bond angles of the 
amine to open up causing more s character to be used in the 
bonding and more p character to be left in the lone pair 
[99] which is poorly suited for donation to an acid. This 
is called back, "B-strain". 
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Figures 15 and 16 show the deprotonation function Q of the 
Zn-DMO and -DEO systems. As was the case with the Cu 
systems, the curves show a total loss of four protons in the 
final MLH species. 
-z 
At the beginning of the titration the 
Q shows a loss of one proton while n = 2 showing that 2 
protons are still attached to the ligand. With increase in 
pH there is loss of three protons with Q = 3 and n = 1 and 
finally, when Q = 2 and n = 0 there is a total loss of four 
protons. 
Figures 17 and 18 show the species distribution at different 
pH values. These represent the percentage of the Zn 2 + ion 
-present in each species. In agreement with the Q, at the 
beginning of the titration, the Zn has been used to form the 
MLH species. The MLH curve, however, does not follow a 
simple Gaussean curve. It shows the existence of another 
species under the curve, though not so marked in the Zn-DMO 
system. This shape implies that in this region the ML 
species is formed. The amount though is not as much as the 
curves formed by the dotted lines show. The ML species 
could possibly be not a stable species in this solution or 
its formation could be the rate determining step in the 
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TABLE 4 
Logarithms of the overall formation constants, 8 pqr 
76 
for the 
Zn-DMO arid -DEO systems, determined in this study at 25°C 
and 0.15 mol.dm- 3 Na[C1] 
Pkw used = 13.59 
ligand pqr ~ u R pH range 
DMO 111 12.12 + 0.01 64.5 0.014 3 - 7.5 -
11-1 -0.73 + 0.03 -
11-2 -4.93 + 0.01 -
DEO 111 13.47 + 0.02 79.9 0.17 3 - 8 -
11-1 1.1 7. + 0.02 -
11-2--6.55 + 0.06 -
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FIGURE 15 The (a) experimental and (b) curves of Q vs pH 
for the_Zn-DEO system at 25°C and 0.15M (Na) Cl 
.••• = n vs pH 
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Zn-DEO deprotonation curves 
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FIGURE 16 The (a) ex2erirnental and (b) theoretical deprotonation 
curves of Q vs pH for the Zn-DEO system at 25°C 
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Figures 19 and 20 show the formation curves for the Ca-DMO 
and -DEO systems respectively. The symbols represent 
different metal to ligaDd concentrations. In both systems 
the curves are superimposable, showing no existence of 
polynuclear species. However, the two systems are different 
in the complexation ability of their ligands. 
Consider the Ca-DEO system first. There is a ..... :.'-
-stepwise formation sequence up to Z values of 1. In the low 
pA region deprotonation is seen to take place, 
evident in the backward. fanning of the titration curves. 
For the equilibrium 
MLH~ ML + H+ 
the pKa value for the deprotonation of the complex is 4.9, 
whereas the pKa
1
for DEO is 7.04. This decrease in the pKa 
upon coordination of the metal ion cannot be due to an 
inductive effect of the Ca 2 + ion, for coordination is 
occurring at the end of the molecule and deprotonation is 
occurring at the other end. (See page 59) 
82 
This would mean that it is not the protonated amine that 
gets deprotonated b~t: the amide nitrogen. 
The observed model is an accepted one as the theoretical and 
observed curves, Figures 20(b) and (a) respectively, are 
The theoretical curve was plotted using the 
formation constants in Table 5. 
The statistics of the constants are very good, also showing 
agreement between the two subsystems. 
Figure 22 shows the deprotonation curves of the Ca-DEO 
system. At the beginning of the titrations, the Q = 1 and 
n = 2 indicating that effectively one proton of the four 
that the ligand is capable of losing, has been lost due to 
complexation with calcium. As the titration progresses more 
protons are lost with Q = 3 and n = 1 implying that this is 
the MLH_
1 
region with one proton still attached to the 
ligand. Finally, Q = 2 and n = 0 when all four protons have 
been lost. 
Figure 24 shows the species distribution at different pH 
values. They represent the percentage. of the Ca 2 + ion 
present in each species. In agreement with the Q, it can be 
seen that at the beginning of the titration 40% of calcium 
has been used up in the formation of the MLH species. The 
83 
ML species, though present, is a minimal. amount with less 
than 20% of the maximum of calcium forming this species. 
For the Ca-DMO system, a totally different process is 
observed. Firstly, there is only the formation of the MLH 
and ML species. Secondly, the pKa for the deprotonation of 
the complex is 5.9 which is one log unit lower than pKa 1 of 
DMO. This could imply that the nitrogens involved in the 
complexation are the amine nitrogens and that there is no 
deprotonation of the amide protons. However, this is not 
possible in the light of tha following discussion. 
Consider the Irving-Williams series [103]. This series 
which is from Ba 2 +. to Cu 2 + is a measure of increasing 
acidity of the metal which is due to the decreasing size of 
the metal ion. Incorporated in this is the factor of 
hardness and softness of the metal iq_ris'.:canti-'±l'dgands. 
--.., ---"{--.'"-· ..... -.~-";..-- ..... -· 
This 
-
factor states that the greater the number of d electrons, 
the greater is the tendency to favour S > N > 0 ligand in 
complex formation. The alkali earth metals of which 
calcium is one, and other metal ions that have few or no d 
electrons prefer to bind in the order 0 > N > s. Calcium is 
a hard acid [99] and so 'is· nitrogen because of its small 
size, but because of the presence of the polarisable 
substituents attached to it, the behaviour changes. The 
change is to the softness of the series. With the addition 
of an electron withdrawing substituent, the softness is 
84 
reduced [99]. However, both DMO and DEO have similar 
substituents on their nitrogens, and in fact DEO should be 
--· ,~softer than DMO because of the .larger alkyl 
group attached to the amine. To explain ~~hyt· .· th;i~( 
observation is not seen, inductive and steric effe~ts rnust·b~~ 
introduced. Due to the "stacking" of the ethyl groups, the 
electron cloud is confined to a particular region in the 
amine, whereas the methyl groups which are free to "sweep" 
around the amine nitrogen make the area of the electron 
cloud wider thus this process and the inductive effect make 
the DMO a soft base. This phenomenon is comparable to 
ethylenediamine [104]. The soft electropositive hydrogens 









FIGURE 25 : The Irving-Williams effect showing the stability 
of ethylenediamine with the series Ba-Sn 
This discussion, however, has been on the amine nitrogens 
only. The amide nitrogens, although they are having 
















Possible reaction mechanism for the hard acid 
Ca 2 + with DMO. 
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The reaction (a) cannot be detected potentiometrically. 
13 C NMR studies were tried but could not enlighten 
the_situation. 
86 

























FIGURE 19 The {a) experimental and {b) theoretical curves for 







Ca-DEO formation curves 
0 3.4:7.3 mM 
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Logarithms of the overall formation constants, Bpqr for the 
Ca-DMO and -DEO systems, determined in this study at 25°C 
-3 
and 0.15 mol.dm Na[Cl] 
Pkw used = 13.59 
ligand pqr ~ u R pH range 
DMO 110 3.64 + 0.01 29.8 0.09 3 - 8.0 -
111 9.49 + 0.03 -
DEO 110 8.427 + 0.07 -
111 13.334 + 0.02 -
11-1 4.289 + 0.03 -
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FIGURE 21 





The (a) exEerirnental and (b) theoretical deprotonation 
curves df Q vs pE for the Ca-DMO system at 25°C and 
0.15M (Na) Cl .... = n vs pH 
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Ca-DEO deprotonation curves 
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curves of Q vs pH for the Ca-DEO system at 25°C and 






























































The species distribution curves for the Ca-DMO system showing the percentage of 



























































The species distribution curves for the Ca-DEO system showing the percent~ge of 




substituents that are electropositive, experience the remote 
action of the electrowithdrawing oxygen thus making these 
nitrogens hard. In taking this discussion it could mean 
that of the four protons on the ligand, the amide ones are 
those lost during complexation (see scheme). 
The theoretical curve (Figure 19(b)) has been plotted using 
the formation constants in Table 5. There is good agreement 
in both the curves and in the statistics of the constants 
with an objective function of 30 which is much lower than 
100. Figure 21 shows the deprotonation curve. At the 
-beginning of the titration Q = 0 and n = 2 indicating that 
there is no complexation. The Q does not rise to Q = 3 
which means that only a total of two protons out of the four 
has been lost at the end of the titration. Figure 23 shows 
the species distribution. This indicates the amount of 
calcium which is in complex form. It can be seen that even 
at pH 8, 20% of the calcium is still uncomplexed. 
3.5.5 Magnesium 
Figures 26 and 27 show the formation curves for the Mg-DMO 
and -DEO· systems. The symbols represent different metal to 
ligand concentrations. In both systems the curves are 
superimposable showing no existence of polynuclear species. 
The shape of the curve shows a least tendency towards metal-
ligand binding. There is, however, evidence of backward 
94 
fanning which is usually indicative of deprotonation of the 
complex, forming species 1 ike MLH_ 1 , or MLH _ 2 • On! y the 
MLH_ 1 species could be detected in the low pA region. 
Although not evident in the shape of the curves there is 
weak stepwise formation of the species of the form 
MLH ~ 
ML 
+ ML + H 
+ 
+ H 
These are obviously weak complexes as the curves do not show 
any considerable complexation. The theoretical curves 26(b) 
and 27(b), which were plotted using the formation constants 
in Table 6, show good agreement with the experimental 
curves. 
Table 6 shows the overall formation constants obtained in 
this study. The statistics of the constants is low giving 
confidence that the chosen model is a true representation of 
the species in solution. 
The constants of the Mg-DEO system are lower than those of 
the Mg-DMO system. This is in accordance with the pKa 
values of DEO being higher than those of DMO. Therefore, 
the lowered metal complex stability could be attributed to 
the inductive effect of the ethyl groups on the amine 
nitrogen. 
For the DEO equilibrium 
MLH ~= 
+ 
ML + H 
95 
it can be seen that the pKa is 6.8 which is about 0.2 log 
units less than pKa of the ligand. This value gives reason 
to believe that coordination is via the two amine nitrogens 
with the Mg 2 + ion inducing the deprotonation of the second 
proton. Therefore the third deprotonation to give the 
MLH species is occurring on the amide nitrogen. A similar 
argument holds for the Mg-DMO system. The pKa for the 
deprotonation of the complex is 5.9 whereas.the pKa
1 
is 6.8, 
a difference of 0.9 log units. Although this value is 
higher than 0.2 log units for the Mg-DEO system, it is still 
acceptable in the above argument. 
Comparing the stability of Mg and Ca, both these are alkali 
earth metals. It has been found that the formation 
constants for Mg are lower than those of Ca. The usual 
trend in the complex stability of the alkali earth metals is 
Mg > Ca > Sr > Ba. [105] This exception to the rule has 
also been observed in the Ca-EDTA and Mg-EDTA stability 
constants. [105] The reason given is that coordinating a 
small ion like Mg 2 + with such a large ligand EDTA is 
difficult. The same reasoning could be applied here with 
DEO being too large a ligand to coordinate well with Mg. 
However, the DMO complexes for both Ca and Mg have similar 
96 
formation constants with Mg being stronger and forming 
MLH_1 . 
Figures 28 and 29 show the deprotonation curves. At the 
beginning of the titration Q = 0 and n = 2 implying that 
there is no complexation. In the case of DEO it is only 
above pH6 that Q begins to rise and complexation takes 
-place. Before intersection of the Q and n curves, ML 
or r-:ILH species are formed but after the two curves inter-
sect, the presence of deprotonated species is indicated. 
,. 
For these systems, the deprotonation function is hot as 
easy to interpret as the ~ function. This is particularly 
so for the DHO system where 6 is seen to rise and then 
fall. This decrease in 6 is due not to a decrease in 
complexation but a decrease in the number of protons which 
can be displaced (i.e. ~l. 
Figures 30 and 3l show the species distribution. This 
indicates the amount of magnesium which is in complex form. 
For the Mg-DMO system the predominant species is ~ ,, ,./ ML, 
whereas for the Mg-DEO system none of the species is 
dominant. In the high pH region MLH_1 · shows the 
possibility of being the dominant species. 
' 
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FIGURE 26 The (a) experimental and (b) theoretical curves for 
the Mg-m10 system at 25 °C and 0. 15M (Na) Cl 
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FIGURE 27 The (a) experimental and (b) theoretical curves for 
the Mg-DEO system at 25°C and 0.15M (Na) Cl 
99 
TABLE 6 
Logarithms of the overall formation constants, s for the 
pqr 
Mg-DMO and -DEO systems, determined in this study at 25°C 
_3 
and 0.15 mol.dm Na[Cl] 
Pkw used = 13.59 
ligand pqr ~ u R pH range 
DMO 110 3.82 + 0.001 72,9 0.07 3 - 8.5 -
111 9.74 + 0.01 -
11-1 -4.65 + 0.02 
DEO 110 1.74 + 0.05 38.5 0.04 3 - 8.5 -
111 8.56 + 0.05 -
11-1 -5.95 + 0.01 -
a:: 
100 
Mg-DMO deprotonation curves 
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FIGURE 28 The (a) experimental and (b) theoretical deprotonation 
curves for the Mg-DMO system at 25°C and 0.15M 
(Na) Cl ... = n vs pH 
a::: 
1 01 
Mg-DEO deprotonation curves· 
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FIGURE 29 The (a) experimental and (b) theoretical deprotonation 
curves for the Hg-DEO system at 25°C and 0.15M 











































































































































Figures 32 and 33 show the formation curves for the Mn-DMO 
and -DEO systems. The symbols represent metal to ligand 
concentrations. Like the Mg-DMO and -DEO systems the shape 
of the curves shows least tendency toward complexation. In 
both systems the curves are superimposable showing no 
existence of polynuclear species. In the backward fanning 
of the curves the species that could be detected is the 
MLH_
1 
only. Figures 32(b) and 33(b) show the theoretical 
curves plotted using the constants in Table 7. There is 
good agreement between the two subsystems. 
Table 7 shows the overall formation constants obtained in 
this study. The models chos~n for the systems are the true 
reflection of the species in solution. This is indicated by 
the statistics of the formation constants. The constants 
are so close to those of the Mg-DMO and -DEO systems that 
similar arguments apply in these Mn-DMO and -DEO systems. 
However, in the Mn-DEO system the ML species could not be 
detected without causing high error in the statistics. 
Therefore the simple model was chosen. 
For the DMO equilibrium 
MLH + ML + H 
105 
The pKa value is 5.82 while pK~ of the ligand is 6.8. The 
difference between the two pKa.' sis 0.98 which is acceptable 
for the argument that coordination occurs at the amine 
first. The inductive effect of the Mn 2 + ion enhances the 
loss of the second proton faster than in protonat.ion. The 
constants for the species MLH and MLH in both systems are 
-1 
equal. This means that there is most likely a property that 
contributes to the weakness of the complexes which is not 
the same as in the other metal ions studied. 
Mn has properties that are similar to Fe. Mn is capable of 
a number of oxidation states and is also fairly 
electropositive. Usually the metal ion Mn 2 + forms 
complexes which possess high spin 3d 5Mnii, hence there is no 
ligand field stabilisation energy. [106] Due to this 
property Mn 2 + forms complexes with low stability constants, 
lower than Fe 2 + through to Cu 2 +. 
Figures 34 and 35 show the deprotonation curves. As in the 
protonation curves, only one inflection is evident for the 
• 
loss of two amine protons. When n = 1 there is one proton 
left on the ,ligand out of the four the ligand is capable of 
losing. The Q and n intersect at Q = 1. At this stage 
three protons have been lost from the ligand due to 
complexation. At the end of the titration the curves are 
vertical showing precipitation. 
106 
Figures 36 and 37 show the species distribution indicating 
the amount of manganese present iri each species. In both 
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Mn-DEO deprotonation curves 
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FIGURE 35 The (a) experimental and (b) theoretical deprotonation 




Logarithms of the overall formation constants, s for the pqr 
Mn-DMO and -DEO systems, dete·rmi ned in this study at 25°C 
and 0.15 mol. dm -3 Na[Cl] 
Pkw used = 13.59 
ligand pqr spqr u R pH range 
DMO 110 3.869 + 0.005 71.59 0.03 3 - 7.5 -
111 9.751 + 0.01 -
11-1 -3.75 + 0.01 -
DEO 111 9.50 + 0.03 60.1 0.05 3 - 7.5 












Mn-DMO formation curves 
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FIGURE 32 The (a) experimental and (b) theoretical curves for 
the Hn-DHO system at 25°C and 0.15H (Na) Cl 
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Mn-DEO formation curves 
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FIGURE 33 The (a) experimental and (b) theoretical curves for 
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Species distribution curves for the Mg.-DEO system at -·a concentration of 4mM. 
114 
3.5.7 Nickel 
Figures 38 and 39 show the formation curves for the Ni-DMO 
and -DEO systems respectively. The symbols represent 
different metal to ligand concentrations. In both systems 
the curves are superimposable showing no existence of 
polynuclear species. However, the shape of the curves shows 
weak complexation. In the middle of the titrations the 
curves show a tendency towards being perpendicular to the pA 
axes. This is the section where precipitation started, 
continuing towards neutral pH. At the end of the titrations 
the curves show a great deal of backward fanning which 
implies that the species dominant in these systems is the 
deprotonated complex, MLH 
-1 
39(b) show the theoretical 
or MLH • 
-2 
Figures 38(b) and 
curves plotted using the 
constants in Table 8. There is good agreement between the 
two subsystems. 
Table 8 shows the overall formation constants obtained in 
this study. The statistics of the constants is good giving 
confidence that the chosen model is a true representative of 
the species in solution. 
The constants of the Ni-DEO system are lower than those of 
the Ni-DMO system. The lower constants could be attributed 
to the inductive effect of the ethyl groups on the amine 
nitrogen. This is in agreement with the pKa values of the 
115 
ligands, i.e. pKa values of DEO are higher than those of 
DMO. There is no detectable stepwise formation as in 
MLH 
ML 
which means that the 
+ 
+ H 
amine protons are lost almost 
simultaneously, possibly due to the inductive effect of the 
Figures 40 and 41 show the deprotonation curves. When Q = 
-0, n = 2 implying that no protons have been lost due to 
complexation. However, there is a sharp rise to.Q = 1 
indicating the loss of the two amine protons, while n = 1.7 
implying that there are two protons still attached to the 
ligand. With increase in pH there is loss of three protons, 
- - -
Q = 3 and n = 1. At the end of the titration when Q = 2, n 
is not quite zero. This is because the titrations were 
terminated due to the presence of a precipitate. 
Figures 42 and 43 show the species distribution which 
indicates the amount of nickel in each species. From these 
figures it can be seen that the dominant species is the 
1 1 6 
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FIGURE 38 The (a) experimental and (b) theoretical curves for 
the Ni-DNO system at 25°C and 0 . 1 511 (Na) Cl 
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Ni-DEO formation curves 
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FIGURE 39 The (a) experimental and (b) theoretical curves for 
the Ni-DEO system at 25°C and 0.15M (Na) Cl 
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TABLE 8 
Logarithms of the overall formation constants, Bpqr for the 
Ni-DMO and -DEO systems, determined in this study at 25°C 
-3 
and 0.15 mol.dm Na[Cl] 
Pkw used = 13.59 
ligand pqr ~ u R pH range 
DMO 111 10.66 + 0.03 86 0.015 3 - 7.5 -
11-1 -0.81 + 0.01 -
11-2 -6.61 + 0.01 -
DEO 111 9.79 + 0.03 44 0.13 3 - 7.5 
11-1 -1.52 + 0.01 -
11-2 -7.70 + 0.03 -
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pH 
The (a) exQerirnental and (b) theoretical deprotonation 
curves of Q vs pH for ~he Hi-DMO system at 25°C and 
0. 1 SM (Na) Cl . . . = n vs pH 
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The (a) exEerirnental and (b) theoretical deprotonation 
curves of Q vs pH for the Ni-DEO system at 25°C and 
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FIGURE 42 Species distribution curbes for the Ni-DMO system showing the percentage of 
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Species distribution curves for the Ni-DEO system showing the percentage of 









shows the formation curves for the Co-DMO system. 
system data could not be analysed satisfactorily 
of the abovementioned procedures. The reason 
presence of thick precipitate even at very low 
metal ion concentrations. This difficulty, however, is not 
only peculiar to this study. Morris and Martin [107] in 
their studies, found that the Coii ion promotes ionisation 
of amides only at or near pH 10. At this stage 
precipitation will have occurred. To overcome this they 
used 20 : 1 molar ratio of ligand to metal and these were 
studied spectrometrically. 
The Co-DMO system in Figure 44 shows the characteristic bad 
and indefinable curves. However, results similar to the Ni-
DMO system could be extracted. Figure 44(b) shows the 
theoretical curves obtained using the constants in Table 9. 
The agreement is not so good, however, the experimental 
curves do show some resemblance to the theoretical curves in 
their backward curving. 
Table 9 shows the overall formation constants obtained in 
this study. The standard deviation is high which shows the 
difficulty of obtaining true values in the presence of a 
precipitate. 
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Despite the unfortunate result of a precipitate, 
interpretation of the system could be made. As in the Ni-






implying that the amine protons are lost simultaneously as 
the Coii ion is coordinated. This is because of the 
inductive effect of the Coii on the amine nitrogens. 
Figure 45 shows the deprotonation curves. When Q = 0 and n 
= 2 at the beginning of the titration there are no protons 
lost because of complexation. However, there is a sharp rise 
to Q = 1 indicating the loss of the two amine protons. At 
the end of the titrations n ~ 0 and Q ~ 2 implying that 
all four protons on the ligand have been lost due to 
complexation. Titrations had to be stopped because of the 
precipitate in the solution. 
Figure 46 shows the species distribution at different pH 
values. The curves represent the percentage of Co 2 + ion 
present in each species. 
125 
Co FORMATION CURVES 
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FIGURE 44 The (a) experimental and (b) theoretical curves for 
the Co-DMO system at 25°C and 0.15M (Na) Cl 
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TABLE 9 
Loga~ithms of the ove~all fo~mation constants, Spqr for the 
Co-DMO and -DEO systems, dete~mined in this study at 25°C 
and 0.15 mol.dm 3 + Na[Cl] 
Pkw used = 13.59 
ligand pqr spqr U:< R pH ~ange 
DMO 111 10.03 + 0.07 91.3 0.~3 -·-'J 3 - 7.0 - ¥;~~·~ _; 
11-1 -1.76 + 0.05 -
11-2 -8.3 + 0.08 -
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Species distribution curves for the Co-DMO system showing the percentage of 






Most of the metal systems studied were plagued by the 
formation of precipitates. This resulted in the titration 
range being limited to the neutral pH. 
What was envisaged from the studies is that the ligands 
should be highly selective for copper. Modification of the 
core structure, trien, was aimed at achieving this. Trien 
is known in Cu chelating studies. 
Bosnich et al. [82] state the following criteria for 
decision in favour of a particular sterochemistry. 
a) Conformational demands of the ligand 
b) Hydrogen-hydrogen repulsions within the complex or 
steric repulsions between ring substituents 
c) Specific internal interactions, such as hydrogen bond 
d) Cumulative ring-strain 
e) Entropy effects 
f) The size of the central metal ion 
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g) The size of the donor atom 
h) The electronic demands of the central metal ion 
i) Solvation effects and crystal packing forces 
The ligands DMO and DEO have two different types of 
nitrogens with which to bind a metal ion, the amine and the 
amide nitrogens. These have different affinity for the 
metal ion. Generally it is known that the base strength in 
nitrogen donor ligands depends on the availability of the 
nitrogen lone pair of electrons. An electronwithdrawing 
substituent, like an oxygen atom on the nitrogen, decreased 
the basicity while an electron donating substituent, like an 
alkyl group, increased the basicity. However, increasing 
the number of alkyl groups on the nitrogen does not always 
result in increased basicity. The tertiary substituted 
alkylamines are le~s basic than their primary substituted 
counterparts. This anomaly has been explained by the 
solvation effect which increases the apparent strength of 
the amine by hydrogen-bonding. Both DMO and DEO are subject 
to the abovementioned factors. 
Besides the properties of the metal ion, the only difference 
in the stability of the two complexes was the result of the 
alkyl group's inductive effect on the nitrogens. The metal 
DEO systems have lower formation constants than those of the 
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DMO systems. This difference can be attributed to the 
higher pKa v~lues of the DEO over those of DMO as a result 
of the inductive effect of ethyl groups on the amine 
nitrogens. 
On comparing DMO and DEO the above factors have been 
eliminated except conformational strain and steric 
repulsions between ring substituents. The ethylene groups 
attached to the amine of the DEO are bulky and steric 
hinderances should be greater. A solution to this problem 
could be packing of the ethylene groups which could possibly 
create a hydrophobic end of the structure. 
The remarkable stability of the Cu system could .be explained 
by taking into consideration the ability of the ligands to 
encapsulate this small metal ion. However I Ni which .;.has e': 
the same ionic radius size as Cu did not show any increased 
stereoselectivity. 
Williams series 
This can be explained by the Irving-
Mn 2 + < Fe 2 + < Co 2 +.< Ni 2 + .< Cu 2 + > Zn 2 +. 
which shows that Cu is more likely, over all the other metal 
ions in this series, to be coordinated. The low stability 
of the other larger metal ions could be due to their 
arrangement outside the chelating cage due to the resistance 
towards unwinding of the ligand. Another aspect could be 
even if they are also encapsulated by the ligands, the 
132 
resultant structure is of low stability as regards the metal 
ions property. For instance Co 2 + prefers tetrahedral 
complex structure, and Ni 2 + is the same for bulky ligands 
as these are, i.e. 
Co 2 + ion chelation 
complexes are formed. 
Mn 2 + has no ligand 
bulkier than ethylenediamine. For 
by strong ligand fields octahedral 
The high spin complex (d 5 ) for 
field stabilisation energy which 
contributes to its thermodynamic stability. In such cases 
the ligands DMO and DEO could show various facultative 
dispositions [108] which are not very stable as compared to 
the Cu-DMO and -DEO systems. 
Stability of complexes containing chelate rings increases as 
the number of rings increases [87]. However, stability 
decreases as the ring size increases from five to seven 
membered. This latter statement brings in the cumulative 
ring strain effect. In previous studies of similar diamino-
diamide ligands [80 and references therein] fused ring 
systems of five-five-five (5,5,5) have been found to be 
strained. Th~~ relief was brought about by altering the 
ring structure and forming 5,6,5 sequence. The 5,5,5 
structure ring strain cannot however be experienced in trien 
complexes. The explanation is that the ethylene group (the 
middle one) can cause ring puckering which reLieves the 
strain. In DMO and DEO this is not possible. The presence 
of the carbonyl groups in the middle ethylene group forces 
the structure to have a planar configuration. 
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The stability of the complex in the present 5,5,5 system 
could possibly result from the first and third ring's 
ethylene groups adopting a gauche [104] conformation. 
Bearing in mind that empirical formula of a compound does 
not give any information about its stereochemistry, . the 
MLH structure, however, can be proposed. 
In this hypothesised structure in solution allowance has 
been made for the bulky ethylene groups. Cu ion is six 
coordinated in a square planar ring with the two longer and 
weak bonds, above and below the ring plane, coordinated to 
water molecules. 
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Comparing a series of ligands which are similar in the 
elemental composition of their chelate rings, N, N'-bis 
( {aminoethyl) oxal{~.amide (SAO), DMO and DEO the following 
deductions are made: Stereoselectivity seems to increase 
with increasing size of the side-chain on the amine 
nitrogens i.e. H<<CH 3 < CH 2 -CH 3 , resulting in the formation 
of the neutral species. 
TABLE 10 
Logarithms of the overall protonation and formation 
constants of the cu, -SAO, -DMO and -DEO systems 
lisano SLH SLH SML SMLH BMLH ref 
2 -1 -2 
SAO* 9.31 17.74 9.41 109 
DMO 6.85 12.8 9.2 3.44 -2.94 this study 
DEO 7.04 13.26 8.74 3.71 -2.98 this study 
* conditions: 22°C in O.lM KNO~ 
The formation constants are presented in Table 10. For the 
ML species similar constants are obtained with these three 
ligands. The selectivity can be observed in the sequence 
(BAO) to (DMO) and to (DEO), for_the MLH_
2 
species. In the 
SAO studies, the authors experienced a great deal of 
precipitation at about pH 7. They concluded that no stable 
compounds were formed with Cu 2 +. Only ML which was formed 
at approximately pH6 was evident. 
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It seems, however, that very little change would be observed 
if an extra cH·o group was added to the ethyl group at the 
2 
amine, thus making it longer. This is postulated from the 
graphical-~preseil.tations· irt Figure 4 7. 
The stability seems toreach a plateau at ligand = DEO. The 
side-chain length effect is also observed in dipeptides. 
[110] On going from Ala-Ala* to Leu/Leu** the difference in 
the complex stability ranges from 0.15 to 0.4 log units. 
The DMO and DEO systems are very similar to those of the 
dipeptides except that carboxylic group are involved in 
complex formation in the peptide systems. 
The metal ions Co2 +, Ni 2 + and Cu2 + which share a number 
of properties have presented interesting results. These 
ions also share the property that they can either be hard or 
soft, and form complexes with N-containing ligands. 
For the first transition series, the stability constants are 
roughly in the order of ionic potential (i.e. charge to 
ionic radius) and size of the metal ions. The sequence of 
the divalent transition metal ions known to promote amide 
deprotonation in glycylglycine (a dipeptide) in increasing 
order of effectiveness is Coii < Niii < Cuii. [107] 
* 
** 
Alanin - Ala-nine 
Leu = Leucin~ 
10 
-+- 8 
c ~ MLH-2 
0 
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FIGURE 47 : Bar chart showing the effect of increasing the amine side chain by CH 
2 
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Quantitatively, the most successful metal ion in promoting 
the deprotonation was Cui!. At pH < 7 the amines as well 
as the amides were deprotonated. 
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CHAPTER 4 




Spectral properties c:(~:e>d~-:;='-:tc;:,fiitfet:~ll~~~~-0.-~ 
between the ground state and the excited state of -... 
molecules. Electronic spectra are much easier to measure 
directly, however, the use of such data is not always a 
trivial matter. Generally light at the visible and 
ultraviolet region of the spectrum is absorbed by a complex 
for a variety of reasons. These are [1] the ligand spectra. 
Ligands like solvents used in complex preparations have 
their characteristic absorption bands which are usually in 
the ultraviolet region. Counter-ion spectra, knowledge of 
the spectrum of the counter-ion that is associated with the 
complex, must be known in order to interpret the spectrum. 
Charge transfer spectra are the result of transitions 
between orbitals that are mainly those of the metal ion and 
those of the ligand. Ligand~field spectra are from the 
split d-orbitals of the metal, having been split in a 
ligand field and these are known as the d-d spectra. 
For a given metal ion, ligands can be arranged in order of 
increasing ~(lODq, the ligand field splitting parameter). 
This order which is more or less independent of the nature 
of the metal ion is called the spectrochemical series. [87] 
<< oa- << = NH < 
:l 
en < bipy < phen < CN 
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This series implies that if the position of maxima in the 
spectrum of n+ m with one ligand is known, approximate 
predictions about the position of the bands for complexes of 
this metal ion with other ligand can be made. Variations to 
the general rule may occur. 
The Cuii ion has a d 9 electronic structure. It has the 
largest spin orbit coupling coefficient. However, complexes 
of Cuii are characterised by a single broad poorly resolved 
absorption band. Frequently Cu complexes are found to have 
highly distorted sttuctures - Jahn-Teller distortion - which 
results in stereochemistries of uncertain description. [113] 
This is the reason why the above generalised results cannot 
be used in determining copper-coordination geometries. 
With the introduction of proteins into the system the 
situation becomes more complex. In conventional chemistry, 
stereochemical regularity is the norm, however, natural 
ligands provide an irregular distorted environment for metal 
ions. The Beer-Lambert's law holds for solutions in which 
there are no interactions between the various chromophores. 
However, if there are interactions between chromophores as 
is often the case with proteins, the absorption band can 
either: 
shift to shorter wavelength (blue shift) 





split into two bands 
show increase in intensity (hyperchromism) or 
show decrease in intensity (hypochromism) 
Chromophores of interest in biochemistry are often 
heteronuclear groupings of atoms. This creates unequal 
charge distribution over the atoms, giving rise to a 
permanent dipole movement p [114] which represents the 
charge separation. Absorption of light by a chromophore 
results in a change of dipole moment which gives rise to the 
electric transition dipolep This is the difference 
between the permanent dipole moment of the ground state and 
the dipole moment of the excited state.[114]. 






-38 = 1.63 X 10 . £. 11. l. l. 
dipole strength 
molar extinction coefficient 
A. 
l. 
absorption maximum wavelength 
half band width in nm 
in nm 
(i) 
In a solution with chromophores absorbing light at the same 
frequency, this gives rise to the dipole interaction 
potential V
12 
for chromophore 1 and 2. Taking A 
2 
as the 
wavelength of the absorption maximum of monomers 
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and \+ or \ as the wavelengths of the shifted absorption 
maxima 
(ii) 
c = velocity of light in a vacuum 
h = Planck's constant 
Monomers which are dispersed in solution represent a random 
state for the chromophore. Aggregation to form specific 
dimers, trimers etc. results in a more ordered state, 
therefore giving 
D~ - D~ 
J. J. < 0 
for hyperchromism (iii) 
and D~ - Do > 
J. i 0 
for hypochromism (iv) 
R = random 
0 = ordered 
For the purpose of analysing the splitting or shifting of 
bands, the sign of ~ depends on the relative orientation 
of the transition dipole movement. In this case it is the 
ith transition dipole moment in chromophore 1 interacting 
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with the jth transition dipole moment in chromophore 2. 
Under the Franck-Condon principle there is no change in 
geometry during an electronic transition and hence: 
-+ -+ 
Vij < O(uiuj) for hyperchromism 
i.e. there is a head-to-tail alignment or coplanar 
arrangement and 
-+ -+ 
V .. > O(u.ttu.) 
~J ~ . J 
for hypochromism 
i.e. there is a stacking of chromophores. This is due to 
the strong electric transitions that are in the plane of an 
unsaturated or aromatic chromophore. 
The molecules to be studied are the Cu-DEO and Cu-BSA-DEO. 
The former will be to substantiate the structure postulated 
in potentiometry while the latter tertiary complex would be 
studied to establish the effect that DEO would have on the 
Cu-BSA complex under physiological conditions. 
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4.2 Experimental 
A complex of 1 : 1 ratio DEO to Cu was prepared using 
deionised distilled water at a concentration of 1.85 x 
NaOH was used to vary the pH. All the 
solutions were run at an ionic strength of 0.15 
mol.dm-3 Na[Cl] in the pH range 6.5-10.7. Spectra were 
recorded on a Beckman uv 5260 spectrophotometer at 2S°C. 
For the Cu-BSA studies, crystalline BSA was obtained from 
Miles Laboratory, U.S.A., ;:l~t no 385, fraction V and purity 
98%. To remove any trace of copper that could be 
contaminating BSA, it was passed through a column of Chelex 
100 using acetate buffer pH 5.0 to equilibrate the column. 
The BSA was dissolved in double distilled water and passed 
through the column. The eluate was then dialysed and 
lyophilised and the Cuii content before and after 
purification was determined by atomic absorption using a 
graphite furnace. 
A 1 1 Cu-BSA complex of concentration 2 X 
-4 3 
10 mol.dm- was prepared. As with the Cu-DEO system, 
the ionic strength was 0.15 mol.dm 
-3 
Na[Cl] at constant pH 
7.4. 
-3 
mol.dm solution of DEO at pH 7.4 was 
prepared and added to the Cu-BSA solution in initial lOul 
increments to final 30ul increments. Spectra were recorded 
on a Varian Superscan 3 spectrophotometer at 37°C. 
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The low concentration of BSk, the pH 7.4 and the temperature 
of 37°C were used so as to be as close to physiological 
conditions as possible. The increments of DEO were 
initially lOul up to 30ul until the final concentration of 
DEO was about 2 x 10- 4 -3 mol.dm. • 
146 
4.3 Results and Interpretations 
The spectra of variable pH study of the Cu-DEO system are 
shown in Figure 1. Spectra 2, 3 and 4 form isosbetic points 
between the two peaks. This indicates that in this pH range 
7.0-9.4 there at least two species in equilibrium. The 
spectrum at pH 6.5, however, does not go through the 
isosbetic point indicating the 
in solution. These spectral changes can be explained in 
terms of the species formed in solution at the different 
pHs. 
0·2. 
soo sso l:.oo 650 100 150 
Wavelength in nm 
FIGURE 1 Variable pH spectra for the Cu-DEO system at metal-















Figure 2 shows the species distribution of this system. At 
pH 10, 100% of the copper exists in the MLH species while 
-2 
at pH 7 the copper is distributsd between two species 
( ~ 50% in MLH and another 50 in MLH ). 
-1 
Below pH <~-~~ 
-2 
the ML species became apparent shifting the spectrum to 
higher wavelength. Combining the results of the species 
distribution and the electronic spectra at different pHs, it 
is possi9le to calculate the spectra of the individual 
species. Beer-Lambert's Law gives the th'fEE. s pee i es 
equilibrium 
A = [MLH_ll +oMLH_, [ MLH_,] 1 
) J 
which can be solved for E • The results of this analysis 
are given in graphic form in Figure 3. This figure 
represents the electronic spectra af each species if it 
existed in the solution on its own. These spectra can be 
used to comment on the structure of the different complexes. 
The electronic spectra of · MLH.!4 have extinction 
coefficients of .( lOO,e.mol·~~~~~li'idh_;]:s characteristic of spin 
allowed, Laporte forbidden transition. [115] The 
intensity of these transitions is. slightly higher than 
normal because the Laporte selection rule is strictly only 
true for complexes of cubic symmetry wh.ile in this case the 
copper complexes have a lower symmetry being geometrically 































































FIGURE 2 Species distribution of the Cu-DEO system at metal-ligand of 1 
I I 
10.05 10.50 

















Molar absorbances of the various Cu-DEO complexes 
in the visible region. 
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coefficient of octahedral spin allowed electronic transition 
are 1-10 while square planar complexes have extinction 
2. 
coefficients in the range 10 -10 • The complexes in this 
study are between the latter extremes. Comment can also be 
made on the relative structure of these two complexes. In 
going from MLH to MLH A shifts to shorter 
-1 -z max 
wavelength. The same effect is shown in Figure 4 in which 
NH is added to Cuii. NH is oh the right of H 0 in the 
3 3 .-...... 2 
·spectrochemical series which means that as successive H
2
o 
molecules are replaced by NH I 6. I 
3 
the crystal field 
splitting parameter, increases shifting the spectrum to the 
left. At the same time the symmetry of the complex is 
lowered resulting in an increased absorbance. Based on 






coordination of the copper 
there is a change in the 
and since A 
max 
moves to lower 
wavelength this change is most likely due to coordination of 
















wavelength in nm 
Spectra of Cu(NH 3 )n(H20)6~n showing the Jahn~Teller 
effect on increasing the number of NH 3 molecules, 
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(a) ONH 3 (b) J.NH3 (c) 2NH3 (d) 3NH 3 (e) 4NH 3 










tew<>.~CW\oj- oc.~.,..._cl~Q.\ C......Nio 
T"' .o,ll 
'Ye~~.~~ +otT-r"~o~\·o~h:..'tl~ta<o.l * + 
~uo..v~.b~oa<i P'\f'ct....,'.O.o.l C. .... Nr;:,.., 
.,.s = o,~r 
C._.N._ .T > o.l;! 
* Chromophores indicated involve a clearly resolved shoulder to 
low frequency 
+ In most cases the restriction arises through out-of-plane 
co-ordination by chelate ligand 
FIGURE 5 : Summary of energy ranges for closely related 
Figure 5 
complexes. 
Cu-N chromophores with different sterochemistries 
X 
shows typical wavelength ranges for copper 
From this it can be seen that the Cu-DEO 
complexes all fall in the tetragonally-distorted, octahedral 
range. A compressed tetrahedral structure is unlikely with 
this ligand in aqueous solution. 
ltoo lim 
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Tetragonal distortion of an octahedral structure can result 
in either elongation or compression of the axial bonds. 
~-t~ 
This is given by the tetragonalit-y~·±'acto:l::~-~~-.{113:]. 
T = mean in-plane Cu-L ,distance 
mean out-of-plane Cu-L distance ( i i ) 
From this equation the following can be deduced. If r is 
less than one, then the distortion is by elongatged~~::~'ai;fal 
bonds, however if T is greater than one, the distortion is 
by compression and if the value of T is one then the 
structure is a regular tetrahedron. 








o• 120° 240° Joo• 
FIGURE 6 The circular cross-section of the warped potential 
energy surface. (a) 3 wells of equal energy 
(b) 2 wells of equal low energy and (c) 1 low 
energy well 
(a) In weak coupling, all three Wells have the same energy 
and equal population i.e. the barrier height B is the 
same. 
(b) For B < kT (temperature T), then this represents 
regular octahedral structure which suffers a dynamic 
Jahn-Teller effect. Strong Jahn-Teller coupling gives 
one Well of higher energy. In this state the module 
will be fluxional with interconversion of two elongated 
axes at each copper site. As far as the bond lengths 
are concerned the system would appear compressed 
octahedral. This, however, is a dynamic situation 
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labelled by Hathaway et al. [6] as the pseudo-
compressed octahedral. 
For B > kT, then there arises the static disordered 
situation with all three distortions occurring 
simultaneously. Their elongation axis being misaligned 
in the perpendicular directions. A Cu atom may be 
elongated along any 6f of the two orthogonal axes with 
the third axis unaffected. Crystallographically the 
average of these two mixed systems would be observed. 
This state is referred to as the pseudo-compressed 
tetragonal octahedral or compressed rhombic octahedral. 
In the above instances, B < kT and B > kT I 
crystallography cannot readily distinguish between 
them. This is because they yield averaged distortion, 
the former a time and the latter a statistical averaged 
distortion. 
(c) In Figure 6(c) all the three Wells have different 
energy. If B > kT a tetragonal stereochemistry which 
is statistically distorted and temperature independent 
is observed. The T values range from 0.8-0.85 i~plying 
that 2 axial (out of plane) bonds are 1 anger. (See 
equation (ii)) 
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For B < T a fluxional structure with a value of T that 
is temperature dependent is observed. 
It has been found that most Cuii complexes fall into 
the former (Figure 6(c)) condition i.e. B > kT. [113] 
The values of T in this case are< 1. In Figure 5 the 
region where the Cu-DEO complexes fall in, is that of 
T = 0.8-0.85 which implies that the complexes have a 
tetragonal stereochemistry with two elongated bonds. 
The tetragonal stereochemistry can be further expanded by 
looking at the possible transitions involved. Generally, 
the greater the tetragonality, for example, the longer 
the axial bond in the d 9 Cuii complexes, then the 
greater will be the energy of the d ---d transition. 
z2 x2 -y2 
[113] The broad band which is usually visible in 
electronic spectra of Cuii is an envelope of d ---d -xy x2 y2 
and d d ---d x2-y2 transitions. As the axial bond xz yz 
lengthens, the latter two transitions shift to the blue 
region of the spectrum~ [113] The blue shift ~-
interpreted to imply that as the axial bond weakens the Cui I 
ion attracts the in-plane ligands more strongly. This 
results in orbitals becoming more antibonding 
and the d d orbitals becoming more stable. This means xz yz 
that in the Cu-DEO complex there are therefore 4 short, 
planar and strong Cu-N bonds and 2 long, axial and weak Cu-0 




The effect of increasing tetragonal elongation eventually 
removes the axial ligands from coordination sphere of the 
central atom which leaves a square planar structure. This 
implies that there is no sharp line dividing the tetragonal 
from the square structure.[87] 





complexes depicted in Chapter 3 are consistent with 
these results. 
Figures 7 and 8 show the spectra obtained in the study. 
Looking at the spectra it can be seen that there is a broad 
band in the visible region (A - 526nm) and.another in the max · 
near UV region of the spectrum. Comparing the Cu-BSA 
complex with hemocyanin, a copper proteiri, the latter shows 
similar bands (Figure 9). These bands have been assigned to 
the copper moiety of the protein- [119] As can be seen from 
the spectra BSA and DEO do not absorb in the visible region. 
~~- J --,·----·-··· .............. . 
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wavelength in nm 
The visible and near-UV spectru~-of hemocyanin, 
bands (a) and (b) arise from the copper moiety 
A number of factors have to be borne in mind in these 
spectra analyses. The structure of the albumin is single 
strand polypeptide. It is known that proteins show a great 
deal of hyperchromism in the UV region with denaturing. 
[114] In these spectra, however, this property can be ruled 
out since BSA does not absorb anywhere near the scanning 
region and it is unlikely that its denatured structure would 
do so. 










(a) obtained in this study 
(b) HSA = human serum albumin 






= 101.5 1 mol- 1 cm- 1 
= 101 1 mol-1 cm- 1 
(c) 
The bovine, rat and human serum albumin have similar 
sequence of the amino acids in the (l-24)NH~ terminal of the 
protein.[61] The absorbance wavelength of the CU-BSA and 
Cu-HSA complexes are very similar and so are the extinction 
coefficients. With the similarity in extinction 
coefficients and the binding site of the BSA to that of HSA, 
it is therefore apparent that the cu-BSA complex prepared in 
this study is similar to the Cu-HSA in structure. This 
means that during the purification of BSA the copper binding 





b?th a shift to longer 
in intensity as the DEO 
concentration increases. The red shift is highly evident in 
the near UV region. This could be due to the increase in 
DEO since the Cu-DEO complex has an intense band in the UV 
region. (See Figure 8) 
162 
The interpretation of this phenomenon is that with increase 
in DEO, the copper is removed from the BSA and so the Cu-DEO 
peak increases while the Cu-BSA peak decreases. The latter 
is evident by the 'flattening' of the \ of about 526nm, 
max 
as a result of being swamped by the Cu-DEO peak. 
Only qualitative results can be discussed here as the 
quantity of copper removed per increment of DEO cannot be 
determined under the conditions of this study. Also the 
exact mode of action of DEO is not clear. It could be any 
of the two possible ways, one that DEO is competing with BSA 
for copper and from the increase in absorbance, it can be 
implied that the copper ion is released from BSA straight on 
to the DEO. Another possible way could be that DEO attaches 
itself on to the protein, thus changing the structure of the 
protein which enhances the release of copper. The latter 
method is similar to that postulated for D-penicillamine. 
- [44] 
The conclusion arrived at in this study is that DEO is 
capable of removing copper from BSA in vitro. The challenge 
from endogenous amino acids in vivo is modelled using the 
computer blood pla~ma model ECCLES. [26] The mode of action 





SUPEROXIDE DISMUTASE ACTIVITY TEST 
not quite clear how electron flow in the chain is 
coordinated to yield four electrons. One suggestion is that 
the cytochromes may be functioning in pairs. This could be 




Superoxide and other free radicals contribute significantly 
to sustaining chronic inflammation by promoting connective 
tissue degradation. The autoimmune response of RA is also 
initiated and maintained by these radicals. A typical 
polymorphonuclear leukocyte population in RA synovial fluid 
is reported as 10 7 cells cm- 3 [121] and .on the other hand 
superoxide radicals are released extracellularly by 
activated polymorphonuclear leukocytes at a rate of up to 
lOnmol 10- 6 cell- 1min-: U2~ Thus there is a large potential 
source of free radicals within the synovial cavity. 
Consider the reactions involved in the cells of a healthy 
subject. During the transportation of electrons to 
molecular 0
2 
via the mitochondrial respiratory chain, as 
well as in various hydroxylation and oxygenation reactions, 
toxic, partial reduction of products of oxygen may be 
formed. These toxic substances 0~ and H 0 are presumed to 
2 2 
be transient intermediates on the active site of the enzyme 
involved [123] and are capable of irreversible damage to 
various biomolecules. There is, however, some uncertainty 
in the electron transport chain of the mitochondria. It is 
not quite clear how electron flow in the chain is 
coordinated to yield four electrons. One suggestion is that 
the cytochromes may be functioning in pairs. This could be 








[o:j~o 2 - - 2- + 0 ~02 ~ 0 2 - e + 0 ~0 ~ H 0 2 2 ~ 2 
Ht 2H1 2Hi H1 
HO H 0 H 0 OH" 
2 2 2 2 
However, evidence indicates that the enzyme involved in the 
intermediates' formation is an Fe-sulfur protein [125]. 
This protein is involved at several points in the NADH to 
oxygen chain. The protein serves to bind the intermediates 
thus forming Fe-superoxides, Fe-peroxide and Fe-oxide which 
are transferred to the enzyme substrate to complete reaction 
to H 0 and the free enzyme. 
2 
There is inevitably some 
leakage of the intermediates from the various reactions. 
The flux is, however, low. [124] 




20 + 2H __,. H 0 + 0 
2 2 2 2 
The resultant toxic H 0 
2 2 
is decomposed by the heme enzyme 
catalase, a flavoprotein oxidase found in the peroxisomes. 
,H 0 ~ H 0 + ~0 
2 2 2 2 
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Therefore dismutase and catalase are interdependent in their 
protective action. Ascorbic acid, glutathione and vitamin E 
support these enzymes in serving as scavengers of the free 
radicals. 
Superoxide dismutase is found in two forms, one in the 
extramitochondrial cytosol and the other form in the 
mitochondria. [125] The mitochondrial form contains 
2+ 
Mn and has a structure similar to superoxide dismutase of 
bacteria. The cytosol form has a different structure which 
2+ 2+ 
contains Zn and Cu The dismutase is present in high 
concentration and is extraordinarily active. This suggests 
that as soon as superoxide radicals are produced during 
oxygen reduction in the tissues they are quickly removed. 
Extracellular fluids are poor in superoxide dismutase, 
however the human serum has antioxidants which protect the 
cell. They function by limiting the reactivity of metal 
catalysed production of radicals and their peroxide 
intermediates. [126, 127] 
During phagocytosis, that is the process of engulfment of 
external solid microorganism by the cell membrane, the 
phagocytic leukocytes engulf these alien objects in the 
plasma membrane envelope. The leukocytes deliberately 
produce both 0 and H 0 to destroy· these microorganisms. 
2 2 2 
These leukocytes are therefore fused with lysosomes and can 
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be released as puss. Under conditions where the leukocytes 
are not overloaded, these highly reactive . entities are 
retained in the phagocytic vacuole. Damage therefore will 
only occur at the target cell. Under acute conditions, 
however, these toxic products are released into the 
extracellular fluid. This is the reason for the increased 
flux of o; in the plasma. [124] 
Lipid peroxidation, i.e. an oxidative deterioration of the 
unsaturated fatty acid molecules, is mediated by the free 
radicals. [9] Hydrogen atom abstraction in this reaction is 
the cause of a chain reaction which leads to the damage to 
lipid molecules e.g. membrane structure. The damaged lipid 
membrane forms peroxides. 
Iron and copper are known to stimualte peroxidation by 
forming new radicals with the product peroxide. [9, 127] 




This increase$ in 
LO" + LO" + H: 0 
2 2 
free radicals, 




problem occurs in cells with antioxidant protection which 
cannot cope even with normal radical production. Under 
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these conditions digestion of the cartilage and inflammation 
occurs. Products of lipid peroxidation have been detected 
in the synovial fluid of .RA patients. [9] 













antioxidants. Lower levels of serum albumin in RA patients 
might also contribute substantially to lower copper 
antioxidant protection. [9] 
Copper complexes have been 
antiarthritic agents. [47, 57] 
which includes both arthritic 
proven to. be 





inflammatory and antiulcer activities. SAARDs have been 
found to act differently from the above agents in that they 
have superoxide dismutase activity in the synovial fluid. 
They thus act as antioxidants. For D-penicillamine it has 
been shown [186] that its copper complex catalyses the 
dismutation of the o; radical. This could be one way in 
which these drugs act on the RA patient's synovial fluid 
thus rendering them clinically active. 
An in vitro test which has been developed by Roberts and 
Robinson [86] has been used in this study to estimate the 
dismutase activity of the ligands in this research. The 
test is based on the production of o; radicals by purine 
169 
degradation, as in Figure 1. The reaction used in the test 
is: 
hypoxanthine xanthine• 0 xanthine, H+ 
oxidase 2 ' 








where the production of 0 is monitored using NBT 
2 
(nitrobleutetrazolium). The ability of a test complex to 
inhibit 0 production is measured in the presence and 
2 
absence of EDTA where the EDTA is introduced to -simulate 
the competition that the drug is likely to experience with 
regard to other copper che~ating ligands in vivo. Based on 
these results the ligand can be classified as: 
1) Active - if the complex has dismutase-like activity and 
is stable in the presence of EDTA, I << 20pM copper 
5 0 
2) Active and unstable - if the complex has dismutase-like 
3 ) 
activity but is not stable in the presence of EDTA, 






2 OpM copper 




















hypoxanthine l II CH 
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xanthine .~ "~ N~ I 11 CH 
HO_..~ N/ "'-. N/ 
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H 0,0 
2 2 xanthine oxidase 
uric acid 
dearninase 
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5.2 Experimental 
5.2.1 Reagents 
Hypoxanthine, xanthine oxidase (E.C. 1.2.3.2.) grade I, 
nitrobleutetrazolium grade III, Hepes buffer and the 
monosodium salt pH 7.5 were purchased from Sigma Chemical 
Company and used without further purification. EDTA and 
gelatin were purchased from BDH ChemicaL Limited, CuCl -2H 0 
2 2 
from Saarchem Limited, while DEO and DMO were synthesised 
in this laboratory. 
5.2.2 Method 
A modified version of the method of Roberts and Robinson was 
used. 
Solutions of copper and DEO were prepared independently at 
-4 
10 M in lOOmM Hepes buffer (HE buffer) pH 7.5. The copper 
and DEO solutions were then mixed in a molar ratio of 1 : 2 
and diluted with HE buffer to a copper concentration of 
-3 
Increasing amounts of a 10 M EDTA solution, in the 
HE buffer, were then mixed with identical aliquots of the 
Cu-DEO solution and incubated for 1 hour at 20°C. Duplicate 
aliquots of these solutions calculated to give a final EDTA 
concentration of 20pM were taken and tested for superoxide 
dismutase-like activity by the inhibition of the NBT by o; 
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The assay solution for superoxide dismutase-like activity 
contained 20).lM hypoxanthine, SOOpM NBT, lmg/ml gelatin, 
Cu-DEO-EDTA solution and HE buffer in a total volume of 3ml. 
The reaction was initiated by the addition of 30pl xanthine 
oxidase (0.1 units/ml) and was allowed to go to completion 
in the dark overnight at 20°C. The reduced NBT was measured 
photometrically at 500nm on a Varian Superscan 3 
spectrophotometer thermostated at 20°C. 
In parallel with the above assay, control solutions were 
assayed. Inhibition of NBT reduction was calculated from 
the equation: 
% inhibition = X 100 
where AEL = test solution with xanthine oxidase absorption 
Ao = test solution without xanthine oxidase 
AE test solution without Cu-DEO 
AB - test solution without Cu-DEO or xanthine 
oxidase 
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5.3 Results and discussion 
Figure 2 shows the dose-response curves obtained in this 
study. The curve without EDTA shows how active the ligand 
is on its own. The ligand shows percentage inhibition of 57 
even at lpM copper. In the presence of EDTA (20pM), 
however, the value for Iso is 6pM indicating its partial 
stability in competition with EDTA. Under the two 
conditions the 
to a copper 
complex has the same dismutase activity down 
concentration of 7.6pM. Below this 
concentration the activity decreases sharply, presumably due 
to loss of copper from the complex to EDTA. 
For comparison, Table 1 gives a list of clinical 
antirheumatic drugs and the SOD-like activity of their 
copper complexes. Most of these ligands have been used 

















(b) obtained in this study 
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(a) ref. [86] 
From the table the SAARDs have similar activities, for 
example D-penicillamine, thiola and captopril, while NSAIDs, 
for example, aspirin and indomethacin are active but 
unstable, see clarification in Section 5.1. Based on these 
observations DEO has activity similar to that of D-
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chelating ligand but also the results show that it has the 
ability to dismutase superoxide radicals. 
Table 2 shows the structure dismutase activity relationships 
for a series of polyamines. From the table it can be seen 
that ethylenediamine and its derivatives have a fairly high 
dismutase activity. The variation in activity can be 
explained by the difference in stability of their copper 
complexes. With increase in chain length, the stability of 
the copper complexes decreases and so the ligand is not able 
to comp~ete with EDTA. 
The addition of an electronegative group to the structure 
e.g. adding COOH to 1,2 diaminopropane forming 2.3 
diaminopropionic acid has improved the stability of the 
complex and also the dismutase activity of the ligand 
increases. DEO has the advantage that at physiological pH 
7.4 it forms neutral species resulting from the 
deprotonation of the amide nitrogens. 
From the table DEO and trien show vast differences in their 
dismutase activity. Categorising these ligands it can be 
seen that trien is EDTA-like in activity while DEO is active 
to the 
used in 
test. Trien is 
the treatment 
a very good copper chelator and is 
of Wilson's Disease [79,80]. It is 
also the core structure of DEO. The amide groups on DEO 
have given the neutral copper complex a high stability and 
TABLE 2 
' 
Compound Structure n R Test activity(a) 
IscfM 
ethylene diamine 1 H 6 
R 
1 1 3 diaminopropane HN -(CH ) -CH-NH 2 H 14 
2 2 n 2 
1 1 4 diaminopropane 3 H 17-20 
1 1 5 diaminopropane 4 H 17-20 
1 '6 diaminopropane 5 H 17-20 
1 1 2 diaminopropane 1 CH 6 
3 
2,3 diaminopropionic acid 1 COOH 5.5 
2,4 diaminopropionic acid 2 COOH 1 1 
0 0 
DEO ,, II 
6(b) NR -(CH ) -N-C - C-N-(CH ) -NR 2 CH -CH 
2 2 n 2 n 2 2 3 
trien H H 2 . 2 
NR- (CH ) -N c - C-N(CH ) -NR 2 H 20 
2 2 n 2 n 2 
(a) reference 86 
(b) in this study 
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the dismutase activity is comparable with other tested 
ligands. 
From this test evidence is growing that a neutral copper 
complex which may favour copper transport and mobilisation 
in vivo is one with the core structure: 
coo-




N - C - C - N 
(found in this study) 
This was also suggested by other workers [12] who did not 
use this method to predict the structure but used computer 
simulated results. It is suggested that this structure can 
possibly form a tertiary complex Cu.L.His with Histidine. 
[86] Histidine has been found to be the vital amino acid in 
the albumin copper binding moeity [61], its I 50 = 4,5uM 
copper. [ 86] 
This core structure has also been found to catalyse 
superoxide dismutation - see Table ~- Such low molecular 
weight complexes have been tested using computer models 
[85] and were found not to be good copper mobilisers in 
vivo. DEO has the advantage that it only forms a 1 : 1 
neutral copper complex and does not rely on ternary complex 
formation for stability. 
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The structure activity relationships table can therefore be 
useful in identifying more suitable candidates for trials as 
potential antirheumatic agents. 
In conclusion, although DEO has not been subjected to 
clinical tests, from the above results i.t is a promising 
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6. General Discussion 
The ligands DEO and DMO are diaminodiamide ligands, however, 
the heavy alkyl groups on the amine nitrogen has made the 
amino character more pronounced than the amide one. This is 
evident in the fragmentation patterns of their mass spectra. 
The basicity of the two amine nitrogens in each ligand is 
virtually the same. This is manifest in their protonation 
studies where the formation curves show only one inflection {page 56) 
(Figure 3.6). The difference in the LH1 and LH2 constants is 
about 0.8 log units. This trend is observed in similar 
structured ligands, e.g. 3,7-diazanonane-1,9-diamine (I), 
1,9diamino-3,7-diazanonane-4,6 dione (II) and BAO (III) all 







NH H N) 
2 2 
log Kl log K2 [68] 
I X = H n = 1 10.25 9.5 
II X = 0 n = 1 9.08 8.82 
III X = 0 n = 0 9.23 8.48 
For metal complexation, DMO and DEO can be compared to 
linear and macrocyclic dioxotetraamines and also the 
polypeptides. They are similar to polypeptides in that they 
have four donor atoms and also form square planar complexes. 
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Structural differences do, however, exist, like the fact 
that for DMO and DEO the deprotonated amide groups are in 
one chelate ring. Another difference is in the terminal 
amine donors. 
Table 1 shows the equilibrium constants of the different Cu-
ligand systems. Going from L1 to L 3 the stability constants 
of the ML species decreases. This is interpreted as being 
due to the inductive effects of the alkyl substituents on 
the amine nitrogen, hence reducing the metal complex 
stability. For the neutral complex MLH_
2
, DEO and DMO 
(L and L ) have similar constants to L and the tripeptide 
3 2 5 
L ·although the actual values are slightly lower. Generally 
9 
they are about 0.8 log units lower. In both cases, L and 
5 
L , the 
9 
ring cluster is 5.5.6 while DMO and DEO 
have 5.5.5 type. In an individual ring system the five-
membered ring is the most stable, with the six-membered ring 
experiencing strain. However, in a system with linked rings 
as in the case of DMO and DEO, cumulative ring strain is 
experienced. The introduction of -a six membered ring 
in ·the link relieves the strain therefore increasing the 
stability of the complex. In the series in Table 1, the 
most stable complex is that formed between Cu and the ligand 
L • In this macrocycle there are two five-membered rings 
6 
and two six-membered rings. However, L has a similar 
7 
arrangement of the rings but is lower in stability. Looking 
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The numbers in parenthesis show the standard deviation on 
the last digit. 
(a) reference 109 (b) 
(d) 131 (e) 





rings are opposite each other but not including the amide 
ring. The L on the other hand, has its six-membered rings 
6 
also opposite each other but including the amide ring. This 
implies that the two side rings do not play a significant 
role in the complexation but the ring opposite the amide, 
noted as well for L • For the DMO and DEO this observation 
9 
could mean that to improve the formation constant value, 
modification on the structure need only be concentrated on 
the side ·opposite the amide. The side rings overcome the 
strain by adopting the gauche conformation, whereas the 
amide ring is rather rigid and cannot be subjected to this 
type of conformation. 
The cavities of the dioxotetraamines are small enough for 
the Cu II ion to bind to the amine, thus simultaneously 
deprotonating the amide. However, larger cavities show 
little effect of this, e.g. L , L and L which are capable 
'+ 7 8 
of stretching, widening the cavity size. On the other hand, 
the ~ing opposite the amine cannot widen. the cavity to any 
extent without inducing strain because the amide ring is 
rigid. It is this cavity size that ~as banked upon for the 
selectivity of Cu II over other metal ions. 
The Cu II ion is smaller than the majority of metal ions in 
the biological system. Achieving high copper selectivity 
would imply that the metal ion homeostatis is not disturbed 
in the blood plasma. 
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The order of the ability to deprotonate the amide in DEO is 
represented in graphical form in Figure 1. For the 
transition metal ions Mn through to Zn (although not 
classified as a transition metal ion) the peak is observed 
at the Cu II ion. However, for DEO, the Ca II and Cu II 
ions have similar formation constants, with DEO slightly 
lower. This could pose a problem in the mobilisation of the 
metal ions in the blood plasma. However, DMO has no 
significant coordination with the other metal ions, ,-~-o-~~~epi:' 
Cu, that could pose a serious problem. Therefore with DMO 
it seems that the envisaged selectivity has been achieved. 
The reason for the strong coordination would be the small 
cavity together with the weaker basicity than DEO. 
Therefore the Cu II ion is able to deprotonate the amide 
below pH 7 by fitting into the cavity. 
The formation constants of Ca, Cu, Mg and Zn with DEO and 
DMO were incorporated into the computer blood plasma model 
ECCLES [ 2 6 ] programme. The free metal ion concentrations 































DEO and DMO complexes with metal ions showing the 
Irving-Williams series behaviour 




Free concentrations of metal ions in blood plasma model used 
in the simulations 
Metal ions Concentration 
-l 
(mol.dm ) 
Ca 2 + 1.46 X 10 
-l 
-4 
6.73 X 10 
1.9 X 10 
-7 
-13 
4.09 X 10 
The ability of the ligands to be able to compete for metal 
ions with plasma proteins can be estimated using the 
parameter Plasma Mobilising Index (PMI). This parameter is 
- :. ~:-:r.-::;.r ~; 
defined as: .r .... ' -~-~ - -·- ----5:J 
total concentration of the low-molecular-weight 
PMI = metal-ion fraction in presence of drug 
total concentration of the low-molecular-weight 
metal-ion fraction in normal plasma 
Figure 2 shows the PMI curves for DMO and DEO. From the 
curves i~; can be seen that the metal ions most likely to be 
excreted are the Ca II, in the case of DEO and Zn II in the 
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PM! curves for the effect of.(i) DEO on the low molecular weight fraction of calcium: 
ions and (ii) DMO on the molecular weight fractions of zinc and copper ions. Log 
PM! plotted against the log of the ratio by which the total ligand concentration (TL) 





formation of charged species, in this case the MLH_
1
, that 
cannot penetrate the membrane barrier. For DEO the 
excretion can be expected since the formation constants of 
Ca-DEO are greater or equal to the Cu-DEO constants. 
However, the Zn-DMO formation constants are much lower than 
Cu-DMO constants, about 2.0 log units lower, yet Zn~I)is 
showing signs that it will be excreted from the plasma. The 
reason for this is that the free metal ion concentration of 
Zn(II) is 10 6 times higher than that of Cu ~~- Because DMO 
concentration 
virtually all 
is so low, 10- 8 mol.dm- 3 , in 
of the DMO present is taken up by 
the system 
zinc. This 
has serious implications concerning zinc, because if the 
agent DMO is administered into the plasma, it could cause a 
zinc-deficiency. Zinc is important biologically, especially 
in tissue repair processes [ 1~3] and its deficiency could 
lead to serious side effects. 
At higher concentrations about 10-~ mol.dm- 3 of DMO in the 
plasma DMO does mobilise copper but that is not the case 
with DEO. This could suggest that the smaller ligand is the 
nearly ideal one for copper mobilisation. Tying this 
observation up with that of the Cu-BSA, it could mean that 
DMO can compete with the albumin for copper by binding the 
metal ion directly. It is unlikely that the same modus 
operandum for D-penicillamine can be applicable to DMO since 
the oxygen and nitrogen atoms in the ligand can form weak 
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hydrogen bonds, as compared to the disulfide link formed by 
D-penicillamine with the albumin.[34, 44] 
In order for a drug to be active in the treatment of RA it 
need not only be a good copper mobiliser but should also 
have dismutase activity. Superoxide radicals promote 
connective tissue degradation ; (12]· and are therefore 
contributing to the chronic state of the disease. In search 
for an agent that does both, i.e. mobilise copper and also 
have superoxide dismutase activity, natural amino acids were 
tested together with the currently used drugs in RA 
treatment by Roberts and Robinson. [. Q6 .] They found that 
histidine and cysteine competed effectively for copper 
binding and they gave I values . of 4.5 and 
5 0 
respectively. In the plasma, histidine and cysteine are the 
two predominant low,: molecular weight ligands that bind the 
exchangeable copper in plasma. U32] 
The ligands in this study have properties similar to the 
polypeptides in their copper binding properties, and in 
their dismutase activity they are promising to have 
antirheumatic action. DEO has an I value of 6 which is in 
50 
the region between the two active amino acids, histidine and 
cysteine. The advantage DEO and DMO have over these amino 
acids is the ability to form chelates. 
r : 
D; 
1 9 1 
With the above observations the conclusion can be arrived at 
that a polypeptide with a histidine~like structure on one of 
the side rings could work well in RA treatment. Possibly 
the structures similar to those studied by Sarkar et al. 
[ 61 J However the CH groups between the nitrogens would 
2 
have to be two. This is shown to be effective in the 
structure-activity relationship depicted in Chapter 5. 
Finally, DMO is a much better ligand than DEO in mobilising 
copper in the plasma and the SOD activity is likely to be 
similar to that of DEO since the elemental structure is 
similar. 
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